Term
Initial therapy for most patients with RA? |
|
Definition
Methotrexate (Rheumatrex) or leflunomide (Arava) |
|
|
Term
_______ plus ______ for moderate-to-high RA. |
|
Definition
Methotrexate
hydroxychloroquine (Plaquenil) |
|
|
Term
_______ plus ________ plus ________ for patients with poor prognostic features and moderate-to-high levels of disease activity. |
|
Definition
Methotrexate
hydroxychloroquine
sulfasalazine (Azulfidine) |
|
|
Term
The ______ DMARDs ______ and ______ should be reserved for patients with at least moderate disease activity and poor disease prognosis who were not helped by ______ and other ______ DMARDs. |
|
Definition
biologic DMARDs abatacept (Orencia)and rituximab (Rituxan)
methotrexate and other nonbiologic DMARDs |
|
|
Term
______ are the new treatment of choice for spondylitis. |
|
Definition
|
|
Term
______ used to treat sacroiliitis |
|
Definition
|
|
Term
Sjorgren's Syndrome treatment: _____ |
|
Definition
Artificial Tears Artificial Saliva Vaginal Lubricant Avoid anticholinergic medications Treat systemic manifestations with anti inflammatory or immunosuppressive agents |
|
|
Term
RA is characterized by ________. |
|
Definition
Symmetrical inflammatory polyarthritis |
|
|
Term
In RA _______ forms at the interface between synovium and the bone and cartilage |
|
Definition
|
|
Term
Initially in RA _____ cells release _____ and ______, which cause synovial cells to release inflammatory mediators. |
|
Definition
interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-a) |
|
|
Term
Radiographic characteristic of RA is inflamed _______ and _____ cartilage. |
|
Definition
synovial membrane
pitted cartilage |
|
|
Term
The histologic features of the rheumatoid nodule (RA) are irregular zones of ______ surrounded by epithelioid cells (histiocytes) and chronic inflammatory cells. |
|
Definition
|
|
Term
The histologic features of the rheumatoid nodule are irregular zones of fibrinoid necrosis surrounded by epithelioid cells (histiocytes) and chronic inflammatory cells. The epithelioid cells are frequently _______ around the necrotic zone. |
|
Definition
palisaded (Olden time log fence) |
|
|
Term
RA: un/symmetrical ____arthritis. |
|
Definition
symmetrical polyarthritis |
|
|
Term
Morning stiffness in RA lasts _____ as opposed to morning stiffness with osteoarthritis that lasts _____. |
|
Definition
More than one hours
few minutes |
|
|
Term
Late stage RA Joint destruction: _______. |
|
Definition
Boutonniere deformity of thumb
ulnar deviation of MP
Swan Neck Fingers |
|
|
Term
RA Systemic features: RA ______ can occur anywhere. |
|
Definition
|
|
Term
RA Systemic features: _____ and _____ syndrome. |
|
Definition
Caplan’s Syndrome
Felty’s Syndrome |
|
|
Term
Caplan’s Syndrome in RA, there are ______ nodules. |
|
Definition
|
|
Term
Felty’s Syndrom: in RA is characterized by ______ and _____ with recurrent _____ infections. |
|
Definition
splenomegaly & leukopenia with recurrent pulmonary infections |
|
|
Term
RA Clinical Diagnosis: ___________. |
|
Definition
Symmetrical synovitis of small joints: warm, swollen joints with synovial hypertrophy, morning stiffness and fatigue are the classic feature. |
|
|
Term
For patients with early RA (less than 3 months), ________ (along with ______) should be reserved only for patients with high disease activity who have never received DMARDs. |
|
Definition
anti-tumor necrosis factor (anti-TNF) biologic drugs (along with methotrexate) |
|
|
Term
For longer duration RA, _______ are recommended for patients who have not been helped by methotrexate. |
|
Definition
|
|
Term
The three approved anti-TNF DMARDs are: ____________ |
|
Definition
etanercept (Enbrel) infliximab (Remicade) adalimumab (Humira). |
|
|
Term
Types of Spondyloarthropathies: |
|
Definition
Ankylosing Spondylitis Reactive Arthritis Inflammatory Bowel Disease Psoriatic Arthritis |
|
|
Term
Spondyloarthropathy is any joint disease of the vertebral column. WIKI |
|
Definition
|
|
Term
Sacroilitis is inflammation of the ________, which Spondylitis is inflammation of the ______. |
|
Definition
|
|
Term
Enthesitis is inflammation of the ______. |
|
Definition
|
|
Term
Uveitis is inflammation of the ______ and is considered an _______. |
|
Definition
anterior chamber of the eye
medical emergency |
|
|
Term
The Spondyloarthropathies: Sacroiliitis, spondylitis, Enthesitis, and Uveitis all vary in their ______. |
|
Definition
|
|
Term
_____ is most associated with HLA-B27. |
|
Definition
|
|
Term
Ankylosing Spondylitis is characterized by: ________. |
|
Definition
Sacroiliitis 5+ Spondylitis 4+ Peripheral Arthritis 1+ |
|
|
Term
_________ is the new treatment of choice for Ankylosing Spondylitis. |
|
Definition
|
|
Term
Following Ankylosing Spondylitis, _______ is has the second most association with HLA-B27. |
|
Definition
Posturethral Reactive Arthritis |
|
|
Term
Posturethral Reactive Arthritis is characterized by: ________ and involvement of _______. |
|
Definition
Sacroiliitis 3+ Spondylitis 3+ Peripheral arthritis 4+
Eye, GU, GI and heart |
|
|
Term
Posturethral Reactive Arthritis is commonly triggered by ______. |
|
Definition
|
|
Term
Postdysenteric Reactive Arthritis is characterized by _______ and involvement of _______. |
|
Definition
Sacroiliitis 2+ Spondylitis 2+ Peripheral arthritis 4+
GU and eye |
|
|
Term
Inflammatory Bowel Syndrome is characterized by ______ and involvement of _______. |
|
Definition
Sacroiliitis 1+ Spondylitis 2+ Peripheral arthritis 3+
GI and eye |
|
|
Term
Inflammatory Bowel Syndrome is caused by _______ and ________. |
|
Definition
Crohn’s disease & Ulcerative colitis (GI) |
|
|
Term
Psoriatic Arthritis involves ______ |
|
Definition
|
|
Term
Spondylitis is treated with _____. |
|
Definition
|
|
Term
Sacroiliitis is treated with ______. |
|
Definition
|
|
Term
Sjogren's Syndrome is a chronic ______, inflammatory disorder of ________ dysfunction. |
|
Definition
Chronic immune-mediated, inflammatory disorder of exocrine gland dysfunction |
|
|
Term
Sjogren's Syndrome is characterized by, dry ____ and _____. |
|
Definition
|
|
Term
Sjogren's Syndrome has the presence of autoantibodies: ___________. |
|
Definition
(ANA, rheumatoid factor, anti-Ro (SS-A) or anti-La (SS-B) |
|
|
Term
Sjogren's Syndrome is diagnosed by the presence of _____ and biopsy of the ______, which demonstrates characteristics of _______. |
|
Definition
Autoantibodies
Upper lip salivary gland
lymphocytic inflitrate |
|
|
Term
Sjogren's Syndrome is treated with: _______. |
|
Definition
Artificial Tears Artificial Saliva Vaginal Lubricant |
|
|
Term
Systemic lupus erythematosus involves _____ on certain target organs. |
|
Definition
Immune complex deposition |
|
|
Term
Systemic lupus erythematosus partially results from impaired clearance of _______ and ______. |
|
Definition
apoptotic cells and immune complexes |
|
|
Term
90% of the patients with SLE are ____. |
|
Definition
|
|
Term
SLE has 25% concordance in ________ twins. |
|
Definition
|
|
Term
Null alleles with deficiency of ____, ____, or ______ — are a strong risk factor for lupus |
|
Definition
|
|
Term
In 70% of patients with SLE there are ______ autoantibodies present. |
|
Definition
|
|
Term
Other autoantibodies associated with SLE are: __________. |
|
Definition
Anti Ro (ribonucleoprotein complex) •Anti La (RNA binding protein) •Anti C1q (subunit of C1 complement) •Anti Sm (nuclear particles |
|
|
Term
The detection of different autoantibody types in SLE is associated with ______. |
|
Definition
Different clinical manifestations |
|
|
Term
The two most common autoantibodies associated with SLE are _____ and ____ and their main clinical effects are ________ & _______ disease. |
|
Definition
Anti-double stranded DNA Nucleosomes
Kidney and Skin disease |
|
|
Term
SLE Pathogenic autoantibodies in Lupus have properties that enable them to ______. |
|
Definition
|
|
Term
Autoantibody development in SLE is _______ driven |
|
Definition
|
|
Term
In order for the antigen to drive lupus it has to be recognized as _____ and presented by an APC to _____ or from a T cell to a ____. |
|
Definition
|
|
Term
_______ can be provided by apoptotic cells. |
|
Definition
|
|
Term
SLE Clinical manifestations: ____________. |
|
Definition
Rashes, arthritis, glomerulonephritis or nephrotic syndrome, neuropsychiatric lupus, hemolytic anemia |
|
|
Term
SLE can present with a ____ rash. |
|
Definition
|
|
Term
In addition to the butterfly rash, Lupus can present on the skin as ______. |
|
Definition
Discoid Lupus, localized raised areas of skin |
|
|
Term
Drug Induced Lupus is associated with an _____ antigen in 95% of cases and 70% for SLE. |
|
Definition
|
|
Term
______ antigen is associated with 40% of SLE cases and none in Drug Induced Lupus. |
|
Definition
|
|
Term
Mixed connective tissue disease have overlap between _______, _______, and ______. |
|
Definition
SLE, scleroderma, and myositis |
|
|
Term
40% of Mixed connective tissue disease has _______ involvement. |
|
Definition
|
|
Term
Mixed connective tissue disease is associated with the specific Ab, _______. |
|
Definition
|
|
Term
Antiphospholipid syndrome, Clinical manifestations: ___________. |
|
Definition
–Arterial thrombosis (including stroke, MI) –Venous thrombosis –Recurrent fetal loss –Thrombocytopenia –Catastrophic antiphospholipid syndrome |
|
|
Term
Classic Antiphospholipid syndrome presentation is with _______. |
|
Definition
Livedo reticularis, a pale net like rash on the extremeties |
|
|
Term
Antiphospholipid syndrome is diagnosed by detection of the _________ and _______ in the labs. |
|
Definition
Lupus anticoagulant (clots in body though) Antiphopholipid antibodies |
|
|
Term
Key history for individuals with Antiphospholipid syndrome, include ______ & _______. |
|
Definition
|
|
Term
Antiphospholipid syndrome is treated with ______ and _______. |
|
Definition
|
|
Term
Vasculitis is inflammation of the ______. |
|
Definition
|
|
Term
Vasculitis Autoimmune markers include: _________ and ______. |
|
Definition
Anti-proteinase 3 antibodies
Anti-myeloperoxidase antibodies |
|
|
Term
Vasculitis of the large sized arteries includes: __________. |
|
Definition
Takayasu arteritis
Giant cell arteritis
Behcet’s disease |
|
|
Term
Takayasu arteritis occurs in _____ and is characterized by: _________. |
|
Definition
Young women
fever, weight loss, arthritis |
|
|
Term
Giant cell arteritis occurs in _______ and presents with _____. |
|
Definition
>50
Large bulging temporal artery |
|
|
Term
Behcet’s disease is characterized by _________ and _______. |
|
Definition
Mucocutaneous ulcers (oral, genital, ileum, cecal)
Ocular inflammation |
|
|
Term
Behcet’s disease is diagnosed by _______. |
|
Definition
Pathergy, needle stick and look for circle reaction around injection site |
|
|
Term
Vasculitis of Medium sized arteries includes: ___________. |
|
Definition
Polyarteritis nodosa
Buerger’s disease
Kawasaki |
|
|
Term
Polyarteritis nodosa is developed in people who have active ______ and ______. |
|
Definition
|
|
Term
Polyarteritis nodosa are specific to the affected organ but often include: _________. |
|
Definition
skin, heart (MI, heart failure, pericarditis), kidneys (renal failure), and nervous system |
|
|
Term
With Buerger’s Disease aka Thromboangiitis obliterans, blood vessels __________. |
|
Definition
blood vessels of the hands and feet become blocked |
|
|
Term
With Buerger’s Disease aka Thromboangiitis obliterans occurs most in ________. |
|
Definition
Tobacco users (heavy smokers) |
|
|
Term
Kawasaki is the leading cause of _____ in children. |
|
Definition
|
|
Term
Kawasaki affects the _____ arteries and can lead to aneurysms. |
|
Definition
|
|
Term
Kawasaki presents with ______, ______, and _______. |
|
Definition
Strawberry tongue
skin rashes on the middle of the body
edema of hands and feet |
|
|
Term
Vasculitis of the small sized arteries can be _______ mediated or _____ associated. |
|
Definition
Immune complex mediated
ANCA associated |
|
|
Term
Vasculitis of the small sized arteries Immune complex mediated: _______. |
|
Definition
•Leukocytoclastic (cutaneous) vasculitis (Arthus reaction) •Henoch-Schoenlein: children>adults • Cryoglobulinemia; |
|
|
Term
Vasculitis of the small sized arteries ANCA associated: __________. |
|
Definition
•Wegener’s granulomatosus (cANCA) •Churg Strauss syndrome: middle age onset asthma vasculitis •Microscopic polyangiitis (cANCA, MPOab and proteinase 3) |
|
|
Term
ANCA associated Vasculitis of the small sized arteries in Wegener's is due to the autoantibody ________. |
|
Definition
|
|
Term
SYSTEMIC SCLEROSIS (________) |
|
Definition
|
|
Term
Systemic Sclerosis is characterized by: ________, _____, _______. |
|
Definition
Cutaneous and visceral fibrosis
Vascular Dysfunction
Immune activation |
|
|
Term
The Vascular Dysfunction associated with Systemic Sclerosis is responsible for the _________ phenomenon. |
|
Definition
|
|
Term
Classic Antiphospholipid syndrome presentation is with _______. |
|
Definition
Livedo reticularis, a pale net like rash on the extremeties |
|
|
Term
Antiphospholipid syndrome is diagnosed by detection of the _________ and _______ in the labs. |
|
Definition
Lupus anticoagulant (clots in body though) Antiphopholipid antibodies |
|
|
Term
Key history for individuals with Antiphospholipid syndrome, include ______ & _______. |
|
Definition
|
|
Term
Antiphospholipid syndrome is treated with ______ and _______. |
|
Definition
|
|
Term
Vasculitis is inflammation of the ______. |
|
Definition
|
|
Term
Vasculitis Autoimmune markers include: _________ and ______. |
|
Definition
Anti-proteinase 3 antibodies
Anti-myeloperoxidase antibodies |
|
|
Term
Vasculitis of the large sized arteries includes: __________. |
|
Definition
Takayasu arteritis
Giant cell arteritis
Behcet’s disease |
|
|
Term
Takayasu arteritis occurs in _____ and is characterized by: _________. |
|
Definition
Young women
fever, weight loss, arthritis |
|
|
Term
Giant cell arteritis occurs in _______ and presents with _____. |
|
Definition
>50
Large bulging temporal artery |
|
|
Term
Behcet’s disease is characterized by _________ and _______. |
|
Definition
Mucocutaneous ulcers (oral, genital, ileum, cecal)
Ocular inflammation |
|
|
Term
Behcet’s disease is diagnosed by _______. |
|
Definition
Pathergy, needle stick and look for circle reaction around injection site |
|
|
Term
In SYSTEMIC SCLEROSIS, Scleroderma results in ______ skin. |
|
Definition
|
|
Term
SYSTEMIC SCLEROSIS's visceral organ involvement can result in intestinal _______, leading to ______, ______, and ______. |
|
Definition
Intestinal hypomotility Bacterial overgrowth Diarrhea/malabsorption Constipation/bloating |
|
|
Term
SYSTEMIC SCLEROSIS's visceral organ involvement can result in Esophageal _____motility causing ______. |
|
Definition
|
|
Term
SYSTEMIC SCLEROSIS results from a _______ defect in ________, that leads to the ________. |
|
Definition
Metabolic defect in fibroblast metabolism leading to the overproduction of collagen and other matrix proteins |
|
|
Term
SYSTEMIC SCLEROSIS damage is caused by ________ activation and _______. |
|
Definition
Immune cell activation and autoimmunity |
|
|
Term
In SYSTEMIC SCLEROSIS, Connective tissue matrix replaces: _________. |
|
Definition
subcutaneous fat, hair follicles, sweat and sebaceous glands |
|
|
Term
In SYSTEMIC SCLEROSIS, the dermis contains infiltrates of: _______. |
|
Definition
mononuclear cells, T lymphocytes and monocytes |
|
|
Term
Although there is endothelial damage, there is no ________ with systemic sclerosis as there is in Lupus and Wegners. |
|
Definition
No vasculitits (inflammation) |
|
|
Term
Two types of Systemic Sclerosis: _______. |
|
Definition
Limited cutaneous (lcSSc)
Diffuse cutaneous (dcSSc) |
|
|
Term
Limited cutaneous (lcSSc) is characterized by skin thickening that is ________. |
|
Definition
limited to the distal extremities (Fingers, toes and face) |
|
|
Term
Limited cutaneous (lcSSc) results in loss of joint mobility with _______. Their is also a loss of ______ and _____, which leaves the skin dry and prone to ________. |
|
Definition
Contractures
Loss of hair and sweat glands which leads to dry skin that is prone to fissures and infections |
|
|
Term
In Limited cutaneous (lcSSc), ______ involvment is more uncommon. |
|
Definition
|
|
Term
Diffuse Cutaneous (dcSSc) is characterized by Rapid and progressive symmetrical induration of the skin of the __________. |
|
Definition
extremities, face and trunk |
|
|
Term
In Diffuse Cutaneous (dcSSc), visceral organ involvement is common with ______ disease, _______ lung disease, and _______ involvement. |
|
Definition
Visceral organ involvement common with renovascular disease, interstitial inflammatory lung disease and cardiac involvement the most serious. |
|
|
Term
With SYSTEMIC SCLEROSIS, Raynaud’s phenomenon is a _______ response consisting of: _________. |
|
Definition
Triphasic vascular response Pallor Cyanosis Reactive hyperemia |
|
|
Term
Raynaud’s phenomenon May be seen in _____% of pts with SSc and may precede other manifestations by years |
|
Definition
|
|
Term
In addition to SSc, Raynaud’s phenomenon is seen in other connective diseases: __________. |
|
Definition
SLE Dermatomyositis Rheumatoid arthritis |
|
|
Term
The vascular features of SSc, include _____ of the face, hands, chest, and intestines (which may cause _____) |
|
Definition
|
|
Term
The vascular features of SSc, include dilated _______ capillaries and ______ ischemia. |
|
Definition
Dilated nail fold capillaries Digital ischemia, infection and infarction |
|
|
Term
SSc is a clinical diagnosis and is suggested by: _____________________. |
|
Definition
Raynaud’s phenomenon Esophageal reflux – heartburn Telangiectasias Sclerodactyly Antinuclear antibodies |
|
|
Term
For SSc, which type is suggested by the detection of Antinuclear Ab that are Nucleolar Pattern? |
|
Definition
|
|
Term
For SSc, which type is suggested by the detection of Antinuclear Ab that are Anticentromeres? |
|
Definition
|
|
Term
For SSc, 30-50% of dcSSc patients have ______ antibody, which is an auto antibody against _________ and leaves patients with a higher risk for ______ and ____ disease. |
|
Definition
Scl-70
topoisomerase
renal and lung disease |
|
|
Term
For lcSSc patients, 50% have the ______ antibody, which leaves them at higher risk for _______. |
|
Definition
Anticentromere antibodies
Pulmonary Hypertension |
|
|
Term
SSc presentation, CREST Syndrome: |
|
Definition
Calcinosis Raynaud phenomenon Esopageal dysmotility Sclerodactyly Telangiectasias |
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS): ____________ |
|
Definition
Polymyositis Dermatomyositis Myositis associated with malignancy Myositis associated with connective tissue disease Inclusion body myositis |
|
|
Term
The older you get, the higher chance you have of getting _____ and ______ type of THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) |
|
Definition
Malilgnancy and inclusion body |
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are mostly ________. |
|
Definition
|
|
Term
With THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), ______ is inflammation of the endomysial. |
|
Definition
|
|
Term
With THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), ______ is inflammation of the perimysial and blood vessels |
|
Definition
|
|
Term
Anti-Jo 1 (also known as antisynthetase) is associated with which IIMS? |
|
Definition
Polymyositis or dermatomyositis |
|
|
Term
Anti-Jo 1 (also known as antisynthetase) is associated with the IIMS's Polymoysitis and dermatomyositis. It's clinical features are _______ and ______. |
|
Definition
Acute interstitial lung disease Arthritis Raynaud’s phenomenon |
|
|
Term
Anti-SRP is associated with which IIMS? |
|
Definition
|
|
Term
Anti-SRP is associated with the IIMS Polymoysitis. Its clinical features include an _____ onset with severe _______ and ______. |
|
Definition
Abrupt
Severe weakness Palpitations |
|
|
Term
Anti-Mi2 is associated with which IIMS's? |
|
Definition
|
|
Term
Anti-Mi2 is associated with the IIMS, Dermatomyositis, and its clincial features are the ______ sign and _________ |
|
Definition
V sign (shawl sign) Cuticular overgrowth |
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are a ______ type of disorder with ______ present. |
|
Definition
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are associated with: ________ especially, ________. |
|
Definition
Hashimoto’s thyroiditis, myasthenia gravis, primary biliary cirrhosis
connective tissue diseases |
|
|
Term
With THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) there are _______ in a biopsy. |
|
Definition
T cells cytoxic to muscle |
|
|
Term
In addition to the cytoxic T cells against muscle tissue, there is immunoglobulin ______ in dermatomyositis |
|
Definition
deposition and complement components in the capillaries and small arterioles (dermatomyositis) |
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) can occur insidious, over months and present with ________. |
|
Definition
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) can occur Indolent, over years with __________ weakness |
|
Definition
proximal and distal muscle weakness |
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), 50% present with ______, others with _______ indicating cardiac/lung involvement, and others with __________ (_________). |
|
Definition
Myalgia,
Dyspnea
Dermatomyositis (skin eruption prior to myositis) |
|
|
Term
Dermatomyositis (skin eruption prior to myositis) is characterized by a _____ rash that has several different varietis: _______lesions Erythematous rash Poikilodermatous rash Heliotrope rash |
|
Definition
Rthe rash
Gottron lesions/papules |
|
|
Term
Gottron papules consist of _______, sometimes ____ papules, plaques, or macules. |
|
Definition
|
|
Term
Gottron sign for THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) is _________. |
|
Definition
Lesions over metacarpophalangeal and proximal interphalangeal joints |
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) for dermatomyotis presents with a _______ on the anterior ________ or the _______ sign on the _______. |
|
Definition
V shape on anterior chest
Shawl sign on the back |
|
|
Term
EXTRAMUSCULAR MANIFESTATIONS of IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are primarily of _______ involvement. |
|
Definition
|
|
Term
The Extramuscular manifestations of IIMS with Interstitial Lung Disease, 10-30% have the auto antibody _____. |
|
Definition
|
|
Term
Cardiac extramuscular manifestations in Polymyositis and Dermatomyositis include: __________. |
|
Definition
• Heart block • Arrhythmias • Cardiomyopathy |
|
|
Term
Gastrointestinal extramuscular manifestations in Polymyositis and Dermatomyositis include __________. |
|
Definition
|
|
Term
Pulmonary extramuscular manifestations in Polymyositis and Dermatomyositis include __________. |
|
Definition
Interstitial lung disease |
|
|
Term
|
Definition
Polymyositis is a rare inflammatory disease that leads to muscle weakness, swelling tenderness, and tissue damage. It is part of a larger group of diseases called myositis. |
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are diagnosed by a ______. |
|
Definition
|
|
Term
THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), Therapy: _______. |
|
Definition
(Unlike SSc, there is therapy) Steroids Azathiopine Methotrexate Cyclosporine Cyclophospamide Mycophenolate IVIG for dermatomyositis |
|
|
Term
With the IDIOPATHIC INFLAMMATORY MYOPATHIES there is a 2-fold increase in _____ risk. |
|
Definition
|
|
Term
Cardinal feature of OA is the _____ of articular cartilage and the ________. |
|
Definition
progressive loss
remodeling of subchondral bone |
|
|
Term
Joint failure results from a variety of pathways subsequent to _____ or repetitive injury |
|
Definition
|
|
Term
Steps in OA pathogenic development: ________. |
|
Definition
1, stress 2, inflammatory response 3, cartilage breakdown products enhance inflammatory response 4, perpetuation of cartilage damage 5, complete loss of cartilage, erosion of subchondral bone, formation of osteophytes |
|
|
Term
Clinical Features of OA: _______, ______ and ______ examination. |
|
Definition
Pain Stiffness of Short Duration (less than 30 mins, RA is >1 hr) Joint examination |
|
|
Term
Joint examination of OA will reveal _______ with movement, a limitation of _______, and joint _______. |
|
Definition
–Crepitus with movement –Limitation of motion –Joint deformity and/or laxity |
|
|
Term
OA has maximal or minimal swelling? |
|
Definition
|
|
Term
In order to differentiate OA from RA, joints that are not typically involved in OA include: ____________ (unless trauma/conginetal) |
|
Definition
shoulder, elbow, wrist and ankle |
|
|
Term
Joints commonly affected by OA: _______. |
|
Definition
Cervical Spine Lumbar Spine Hips Distal Interphalangeal Knees Metatarsals |
|
|
Term
Palpation of the joints: RA ______ OA _______ |
|
Definition
|
|
Term
Presence of ________ suggests other etiology other than RA. |
|
Definition
extra-articular manifestations |
|
|
Term
Extra-articular manifestation, Fever, is more likely: ________ than OA. |
|
Definition
gout, infectious arthritis |
|
|
Term
Extra-articular manifestation, Rash, is more likely: ________ than OA. |
|
Definition
|
|
Term
Extra-articular manifestation, Nodules, is more likely: ________ than OA. |
|
Definition
|
|
Term
Extra-articular manifestation, Neuropathy, is more likely: ________ than OA. |
|
Definition
polyarteritis nodusa, Wegener granulamatosis |
|
|
Term
Typical hand deformities in osteoarthritis: –__________ on DIPs –__________ on PIPs |
|
Definition
Heberden's nodes
Bouchard's nodes |
|
|
Term
Radiographic Diagnosis of OA: ______. |
|
Definition
Osteophytes (arrows) and medial joint space narrowing more on one side |
|
|
Term
Radiographic Diagnosis of RA: _______. |
|
Definition
Almost complete symmetrical loss of joint space in both the medial and the lateral compartment, but with little subchondral sclerosis or osteophyte formation |
|
|
Term
Three types of OA: _______. |
|
Definition
Erosive inflammatory OA Nodal OA Routine OA |
|
|
Term
Erosive inflammatory OA, flares of _____ occur and is destructive of the ______. |
|
Definition
inflammation
finger joints |
|
|
Term
Erosive inflammatory OA can be differentiated from RA by _______. |
|
Definition
lack of rheumatoid factor and asymmetrical |
|
|
Term
Nodal OA occurs mainly in _____ and has a correlation with _______. |
|
Definition
|
|
Term
In Nodal OA, the ______ joints are mainly involved. |
|
Definition
|
|
Term
Routine OA is due to ______. |
|
Definition
|
|
Term
In the treatment of Mild – moderate OA, ________. |
|
Definition
|
|
Term
In the treatment of Moderate to severe OA, ________ (In order of increasing severity). |
|
Definition
–NSAIDS at lowest effective dose –High-dose NSAIDS plus proton pump inhibitor of misoprostol for gastric protection –Intra-articular corticosteriods –Opiates or synthetic opioids (e.g, tramadol) |
|
|
Term
Proton pump inhibitor drug, _______. |
|
Definition
|
|
Term
Pharmacologic Treatment of OA can be supplemented with ________ or _______. |
|
Definition
Topical NSAIDS or capsaicin |
|
|
Term
Crystals Observed in Joints: _______. |
|
Definition
Monosodium urates Calcium pyrophosphate dihydrate |
|
|
Term
Monosodium urates crystals are associated with ________. |
|
Definition
|
|
Term
Calcium pyrophosphate dihydrate are associated with ________. |
|
Definition
|
|
Term
Monosodium urates crystals are ______ in Tissue and _______ in fluid. |
|
Definition
|
|
Term
Calcium pyrophosphate dihydrate crystals are ______ in Tissue and _______ in fluid. |
|
Definition
|
|
Term
Main classes of people at risk for Gout: ________. |
|
Definition
Men >35 years of age, post-menopausal women, organ transplant recipients |
|
|
Term
Why are post menopausal women more susceptible to gout? |
|
Definition
Estrogen enhances rate of uric acid excretion |
|
|
Term
Serum uric acid levels must be at least ______ to develop gout. |
|
Definition
|
|
Term
10% of the cases of Gout are the result of _____ or _____ of uric acid. |
|
Definition
Overproduction or overconsumption |
|
|
Term
Primary causes of gout account for _____ cases and are _______. |
|
Definition
<2%
Genetic deficiencies in enzymes |
|
|
Term
Secondary causes of Gout include: ________. |
|
Definition
•Myeloproliferative and lymphoproliferative diseases (producing lots of cells and therefore need lots of purines) •Chemotherapy of malignancies (purines from dead cells) •Ethanol consumption |
|
|
Term
_____ of uric acid accounts for 90% of the cases of Gout. |
|
Definition
|
|
Term
Acute gout is characterized by ______ onset of _________, accompanied by _____ and _____. |
|
Definition
Rapid onset of intense pain
Erythema, swelling |
|
|
Term
Most frequent site for first attack of acute gout is ______. |
|
Definition
|
|
Term
Polyarticular gout aka (________) involves _______. |
|
Definition
(gouty arthritis)
multiple joints |
|
|
Term
Chronic tophaceous gout is characterized by ______. |
|
Definition
|
|
Term
Gout is associated with increased levels of urate in the urine, leading to _______. |
|
Definition
kidney stones (calcium oxalate stones – nephrolithiasis) |
|
|
Term
Gout is associated with high levels of Monosodium urate (MSU) which can cause ______ around the joints. |
|
Definition
|
|
Term
Monosodium urate (MSU) deposition is associated with Gout and can cause _______. |
|
Definition
|
|
Term
Podagra / gouty arthritis is characterized by swelling of the ______, and a dusky blue hue over an _________. |
|
Definition
|
|
Term
Tophaceous gout, nodules are _______ and full of _______ and there is no surrounding ________. |
|
Definition
painless
uric acid crystals
swelling or erythema |
|
|
Term
Chronic gout is characterized by chronic ________ with tenderness and swelling. |
|
Definition
|
|
Term
In chronic gout _______ are present. |
|
Definition
|
|
Term
Gout can be differentiated from Septic arthritis by checking for ______. |
|
Definition
|
|
Term
Gout can be differentiated from Cellulitis by checking for ______. |
|
Definition
|
|
Term
Acute gout, in 95% of the patients there was ______ |
|
Definition
Serum uric acid >7.5 mg/dL |
|
|
Term
Monosodium urate crystals are _____ in fluid and _____ refractile |
|
Definition
|
|
Term
Monosodium urate crystals are ______ under polarized light microscopy. |
|
Definition
Negatively birefringent Blue/Red |
|
|
Term
For Acute Gouty attacks, treat initially with the ________, _________. |
|
Definition
|
|
Term
For Acute Gouty attacks, treat with any NSAIDS, especially Indomethacin, but not ______ or _____. |
|
Definition
|
|
Term
In addition to the primary treatment of NSAIDS (Indomethacin) for Acute Gout, _______ can be administered. |
|
Definition
|
|
Term
In order to decrease urate formation, a ________ inhibitor, _________ can be administered for moderate to severe gout to prevent the conversion of ______ to ______. |
|
Definition
ALLOPURINOL
Xanthine oxidase inhibitor
inhibit conversion of hypoxanthine to xanthine to uric acid |
|
|
Term
In order to increase urate excretion, a ______ type of drug called _______ can be administered, which inhibits ________. |
|
Definition
Uricosuric
Probenecid
Inhibits tubular reabsorption of urate |
|
|
Term
NSAIDs first-line treatment for acute gout – _____ or ______. |
|
Definition
indomethacin or COX-2 inhibitor |
|
|
Term
First line for lowering Urate for Chronic Tophi Gout is: a xanthine oxidase inhibitor such as ______ or a uricosuric agent such as ________. |
|
Definition
|
|
Term
Do NOT give allopurinol during _______ – any change in uric acid level worsens attacks |
|
Definition
|
|
Term
______ can be used for prophylaxis treatment of Chronic Tophi Gout. |
|
Definition
|
|
Term
If there is failure to lower uric acid levels with single therapy, use one _______ and one _______. If still unsuccessful add ________. |
|
Definition
1 xanthine inhibitor (allopurinol) and 1 uricosuric agent (probenicid)
pegloticase |
|
|
Term
Patients with hyperuricemia caused by tumor lysis syndrome are treated with ______ or ______. |
|
Definition
Rasburicase (allergenic) or pegloticase (uricosuric agents) |
|
|
Term
Corticosteroids are used to treat which type of gout? |
|
Definition
|
|
Term
Calcium Pyrophosphate Dihydrate Deposition Disease (CPDD) affects _____ and ______. |
|
Definition
cartilage and fibrocartilage |
|
|
Term
Calcium Pyrophosphate Dihydrate Deposition Disease (CPDD) presents as ______. |
|
Definition
Acute arthritis (Often seen in post-op patient) |
|
|
Term
Calcium Pyrophosphate Dihydrate Deposition Disease (CPDD) is diagnosed by the presenced of ______ crystals in the fluid, which are _____ refractive. |
|
Definition
|
|
Term
Calcium Pyrophosphate Dihydrate Deposition Disease (CPDD), Calcium pyrophosphate crystals are ________ bifringment. |
|
Definition
|
|
Term
CPDD, Acute pseudogout is treated with _______ and ______. |
|
Definition
Systemic corticosteroids or NSAIDs |
|
|
Term
CPDD, Pseudo RA is treated with _______ and ______. |
|
Definition
corticosteroids and methotrexate |
|
|
Term
Uric acid is produced from the breakdown of _______. |
|
Definition
purines (adenine, guanine) |
|
|
Term
2/3 of the uric acid in the body comes from ______ and 1/3 from ______. |
|
Definition
2/3 comes from de novo synthesis and/or salvage pathways
1/3 diet |
|
|
Term
Uric acid, 2/3 excreted via _____; 1/3 through _______. |
|
Definition
|
|
Term
Sarcoidosis is a chronic disease of _________. |
|
Definition
|
|
Term
Sarcoidosis is a multisystem _______ disease of _______ etiology. |
|
Definition
|
|
Term
Sarcoidosis is a disease of disordered immune ______ in _______ persons exposed to ________. |
|
Definition
Disease of disordered immune regulation in genetically predisposed persons exposed to certain environmental agents |
|
|
Term
For Sarcoidosis, the diagnostic histopathic feature is _____________. |
|
Definition
noncaseating granulomas in various tissues |
|
|
Term
Sarcoidosis, high levels of ______ cells in the lungs or sites of ________. |
|
Definition
|
|
Term
In Sarcoidosis there is massive local secretion of ____-dependent cytokines-_____. |
|
Definition
Local secretion of Th1-dependent cytokines – IFN-g (by CD4+ T cells ) |
|
|
Term
Primary organ affected in Sarcoidosis? |
|
Definition
|
|
Term
Sarcoidosis 75-95% exhibit _______ whiles 75% exhibit ________. |
|
Definition
lymphadenopathy
spleen granulomas |
|
|
Term
Sarcoidosis primarily affects _____ lymph nodes. |
|
Definition
|
|
Term
Sarcoidosis can affect glands, particularly the ______ resulting in _____ from the production of active _____ by activated macrophages. |
|
Definition
parathyroid gland
hypercalcaemia
Vitamin D |
|
|
Term
Sarcoidosis manifests in the skins as ________. |
|
Definition
erythema nodosum (skin nodules, so does gout) |
|
|
Term
Sarcoidosis, multisystem disease, affects: ________ |
|
Definition
Lungs Heart Skeletal Muscle Liver Lymph Nodes Spleen Glands Skin Eyes Bone Marrow |
|
|
Term
Sarcoidosis surprisingly does not have a higher incidence among ______. |
|
Definition
|
|
Term
Sarcoidosis Appears to be due to development of ______ response against an unidentified antigen |
|
Definition
|
|
Term
Sarcoidosis, there is initially an Intra-alveolar and interstitial accumulation of ______ cells. |
|
Definition
|
|
Term
In Sarcoidosis, the T cell subsets are of ______ origin. |
|
Definition
from one common, Oligoclonal expansion |
|
|
Term
In Sarcoidosis, the CD4+ TH1 cells release TH1 cytokines _______ causing _______, and ______ causing _______. |
|
Definition
IL-2 (T cell expansion) and IFN-γ (macrophage activation) |
|
|
Term
In Sarcoidosis, following macrophage activation, additional cytokines are released resulting in ______. |
|
Definition
|
|
Term
One of the common side effects of Sarcoidosis is the anergy to ______, due to the ________. |
|
Definition
common skin test antigens
peripheral T cell depletion |
|
|
Term
After the T cells have gone haywire in Sarcoidosis, ______ results for the B cells. |
|
Definition
Polyclonal hypergammaglobulinemia |
|
|
Term
Sarcoidosis has genetic involvement and association with certain _____ genotypes. |
|
Definition
|
|
Term
2/3 of Sardoisis cases present with ______ that appeared gradually |
|
Definition
respiratory symptoms (Shortness of breath, cough, vague chest pain) |
|
|
Term
In addition to resp sympts Sardoisis patients also present with ____, ____, _____, or ______. |
|
Definition
peripheral LAD, cutaneous lesions, splenomegaly, or hepatomegaly |
|
|
Term
Sarcoidosis remission may be spontaneous or initiated by ______ therapy. |
|
Definition
|
|
Term
10-15% of Sarcoidosis pts die from _____. |
|
Definition
progressive pulmonary fibrosis |
|
|
Term
Sarcoidosis should be considered for any patients of the age of _________ with _______ complaints, _______ vision, _______ skin condition, or ________. |
|
Definition
20-40 with respiratory complants, blurry vision, erythema nodosum and hilar lymphadenopathy |
|
|
Term
Sarcoidosis WBC will indicate _______ and _______. |
|
Definition
lymphocytopenia and eosinophila |
|
|
Term
Sarcoidosis will show a decreased/increased erythocyte sedimentation rate |
|
Definition
|
|
Term
Sarcoidosis will show hypo/hyperglobulinemia |
|
Definition
|
|
Term
Sarcoidosis labs will show elevated _____ levels. |
|
Definition
ACE (angiotensin-converting enzyme) |
|
|
Term
Definitive diagnosis of Sarcoidosis requires ______. |
|
Definition
|
|
Term
Sarcoidosis ex. presentation: _____________. |
|
Definition
A 26-year-old African American woman presented with fever, malaise, weight loss, and erythema nodosum She reported shortness of breath and dry cough. Radiograph showed hilar LAD and mediastinal LAD; nodules were also present in the lungs |
|
|
Term
Sarcoidosis tissue samples have _______ and an absolute indicator is the presence of ______. |
|
Definition
Noncaseous granulomas
Asteroid bodies |
|
|
Term
Sarcoidosis is treated with a high dose _______. |
|
Definition
glucocorticoid taper (prednisolone) |
|
|
Term
For the treatment of steroid resistant Sarcoidosis: ___________. |
|
Definition
(Autoimmune Drugs) Methotrexate Hydroxychloroquine (antimalarial) TNF-a inhibitors |
|
|
Term
Primary immunodeficiency ______ determined. |
|
Definition
|
|
Term
Secondary immunodeficiency states are the results of ______ and ______. |
|
Definition
Complications of cancers, infections
Side effects of immunosuppression/chemotherapy |
|
|
Term
X-linked agammaglobulinemia (Bruton’s) results from a mutation in _______, causing a ____ cell immunodeficiency. |
|
Definition
|
|
Term
X-linked agammaglobulinemia (Bruton’s) mutation in BTK results in the failure of ________. |
|
Definition
Failure of B cell maturation |
|
|
Term
X-linked agammaglobulinemia (Bruton’s) overall affect is an _________. |
|
Definition
Absence of antibodies, circulating B cells, and plasma cells |
|
|
Term
X-linked agammaglobulinemia (Bruton’s), 20% develop ______. |
|
Definition
develop autoimmune diseases – RA, dermatomyositis |
|
|
Term
X-linked agammaglobulinemia (Bruton’s), infection onset by ______. |
|
Definition
|
|
Term
Selective (isolated) IgA deficiency is the most common ____ deficiency. It is a deficiency of ____ cells. |
|
Definition
|
|
Term
Selective (isolated) IgA deficiency results in a block in ______. |
|
Definition
differentiation of IgA-secreting cells |
|
|
Term
With Selective (isolated) IgA deficiency other than IgA, other Ig are _______. |
|
Definition
Other immunoglobulins normal or increased |
|
|
Term
Selective (isolated) IgA deficiency present clinically with ______. |
|
Definition
early childhood with recurrent sinopulmonary infections and diarrhea |
|
|
Term
Selective (isolated) IgA deficiency has a significant association with ________. |
|
Definition
|
|
Term
Common variable immunodeficiency is characterized by _______. |
|
Definition
|
|
Term
With Common variable immunodeficiency, _______ cells are present, but _______ cells are absent. |
|
Definition
B cells present, plasma cells absent |
|
|
Term
Common variable immunodeficiency is clinically similar to _______, with onset instead around ______. |
|
Definition
Bruton’s agammaglobulinemia
second decade of life |
|
|
Term
Common variable immunodeficiency is a _____ type of immunodeficiency. |
|
Definition
|
|
Term
Common variable immunodeficiency leaves pts prone to developing autoimmune diseases and ________. |
|
Definition
|
|
Term
Another type of B-Cell Deficiency is Transient hypogammaglobulinemia of infancy which occurs ________, when _______ is disappearing and baby B cells are not producing enough. |
|
Definition
3-6 months of age when materal IgG is disappearing |
|
|
Term
DiGeorge syndrome aka (________). |
|
Definition
|
|
Term
DiGeorge syndrome (Thymic aplasia) results from the failure of the development of the _________. |
|
Definition
3rd and 4th pharyngeal pouches |
|
|
Term
DiGeorge syndrome (Thymic aplasia) results in _____, ______, and _____ defects (______ syndrome). |
|
Definition
Cardiac, vascular craniofacial defects
(velocardiofacial syndrome) |
|
|
Term
Complete absence of the thymus and T cells with DiGeorge syndrome (rare) is called _____. |
|
Definition
|
|
Term
Two types of Severe Combined Immunodeficiency Disease: _____. |
|
Definition
|
|
Term
Autosomal SCID are half due to mutations in _______, leading to toxic accumulation during ______ maturation and proliferation. |
|
Definition
adenosine deaminase (ADA)
lymphocyte |
|
|
Term
X-linked SCID is due to mutations in gene encoding _______ leading to loss of ______ receptors. |
|
Definition
common g chain
cytokine (for IL's) |
|
|
Term
With Severe Combined Immunodeficiency Disease May present with graft-versus-host disease from maternal T cells – ________ after birth |
|
Definition
|
|
Term
Severe Combined Immunodeficiency Disease have _____ thymuses, lymph nodes, and mucosal lymphoid tissue. |
|
Definition
|
|
Term
Severe Combined Immunodeficiency Disease presents when? |
|
Definition
|
|
Term
Severe Combined Immunodeficiency Disease presents with? |
|
Definition
Diarrhea, otitis media, thrush, and respiratory infections |
|
|
Term
Hyper-IgM syndrome is an example of ______ Deficiency. |
|
Definition
|
|
Term
Hyper-IgM syndrome is a failure to produce _________. |
|
Definition
isotype-switched high-affinity antibodies (IgG, IgA, IgE) |
|
|
Term
Hyper-IgM syndrome exhibits normal to high levels of ______. |
|
Definition
|
|
Term
Hyper-IgM syndrome, 70% X-linked mutation in gene encoding _____ (T cell) and 30% autosomal, related to mutation in _____ (B cell) |
|
Definition
|
|
Term
With Hyper-IgM syndrome and the failure of CD40-CD40L T-cell mediated activation of ______, pts are susceptible to _______. |
|
Definition
macrophages
intracellular pathogens and Pneumocystis jiroveci |
|
|
Term
Secondary (Acquired) Immune Deficiencies are Much more common than the primary (inherited) disorders, encountered in patients with: ___________. |
|
Definition
Malnutrition Infection Cancer Renal disease SarcoidosisMalnutrition Infection Cancer Renal disease Sarcoidosis************** |
|
|
Term
Most common cause of immune deficiency is _________. |
|
Definition
therapy-induced suppression of the bone marrow or of lymphocyte function |
|
|
Term
|
Definition
|
|
Term
Asprin is a ______ derivative. |
|
Definition
|
|
Term
2 major class of NSAIDS and ex of each: _______. |
|
Definition
Salicyclic acid, Asprin Para-aminophenol, Acetaminophen |
|
|
Term
NSAIDS act by inhibiting the _______. |
|
Definition
cyclooxygenase (COX) enzyme |
|
|
Term
Inhibition of the COX enzyme by NSAIDS, blocks the production of _______ which mediate the pathogenesis of ______ and _____. |
|
Definition
prostaglandins
inflammation and fever |
|
|
Term
Inhibition of COX-_ is responsible for the therapeutic benefits. |
|
Definition
|
|
Term
AA is cleaved from phospholipids by ______. |
|
Definition
|
|
Term
AA is cleaved by _____ and _____. |
|
Definition
|
|
Term
AA cleaved by Lipoxygenase generates ________. |
|
Definition
Leukotrines (bronchoconstirctors) |
|
|
Term
COX-1/2 cleavage of AA leads to the production of _____, _____, and _____. |
|
Definition
Thromboxanes Prostaglandins Prostacyclins |
|
|
Term
Loss of the therapuetic function of COX-1 leads to _____, _____, and _____ problems. |
|
Definition
Stomach (Bleeding/ulcers)
Hemostatis (loss of Thx, platelet aggregation)
Kidney (PG/PC) |
|
|
Term
COX-1 is a _____ structure found where? |
|
Definition
Dimer
anchored to the membrane |
|
|
Term
What are the two key active site amino acids that bind AA in COX-1? |
|
Definition
|
|
Term
In addition to the key amino acids, what motility also helps binding at the active site of AA by COX-1? |
|
Definition
|
|
Term
Asprin is a unique NSAIDS because it _______. |
|
Definition
Acetylates the serine residue on COX and therefore knocks it out permanetly |
|
|
Term
Asprin is used to knock out COX permanently and deprive ______ cells of ______. |
|
Definition
platelets
Thromboxane A-2 |
|
|
Term
NSAIDS are what kinds of inhibitors? |
|
Definition
Competitive, bind at active site |
|
|
Term
COX-_ is expressed constitutively and in all tissues. |
|
Definition
|
|
Term
COX2 is only expressed constitutively in: _______. |
|
Definition
Brain and parts of kidney |
|
|
Term
COX-2 is involved in the _____, while COX-1 is involved in ______. |
|
Definition
Inflammatory processes
Housekeeping |
|
|
Term
Side effects of NSAIDs because of the block of COX-1: _______ & _______. |
|
Definition
GI ulceration Blockade of platelet aggregation (Inhibition of Thbx synthesis) |
|
|
Term
Asprin is primarily a COX-_ inhibitor. |
|
Definition
|
|
Term
Naproxen (NSAID) is an inhibitor of _____. |
|
Definition
Almost COX-1 and 2 equally (little more COX-2) |
|
|
Term
Selective for COX-2, ______. |
|
Definition
|
|
Term
How do COX-2 selective inhibitors work? |
|
Definition
Bind to side pocket in COX-2 that is not present in COX-1 |
|
|
Term
Celecoxib (Celebrex) was not withdrawn from the market, but other COX-2 selective inhibitors, ______ and ______, was. |
|
Definition
|
|
Term
AA through the COX-2 pathway eventually produces a ____thrombotic Prostaglandin-I2. |
|
Definition
|
|
Term
The addition of Vioxx a COX-2 selective inhibitor, removes ______thrombotic. |
|
Definition
|
|
Term
In platelets, AA through COX-1 (which Asprin targets) produces ______, which is a _____thrombotic factor. |
|
Definition
|
|
Term
The addition of Asprin through the blockage of COX-1 removes a ______thrombotic factor. |
|
Definition
|
|
Term
Vioxx puts you at risk for _____ because it removes an _______. |
|
Definition
|
|
Term
Acetylsalicylic acid (_____) |
|
Definition
|
|
Term
Traditional NSAID as a whole have functions: ______________. |
|
Definition
Anti-inflammatory Analgesia Antipyretic |
|
|
Term
Asprin is the only NSAID that is used for ______ function. |
|
Definition
|
|
Term
All NSAIDs have an Anti-inflammatory function except for _______. |
|
Definition
|
|
Term
NSAIDs achieve their Antipyretic by producing ____ which act on the Hypothalamus. |
|
Definition
|
|
Term
NSAIDs achieve their Analgesia function by ______. |
|
Definition
Lowering pain transmission |
|
|
Term
All currently available NSAIDs inhibition _____ and _____ synthesis via inhibition of COX-1. |
|
Definition
|
|
Term
NSAIDs are ______ protein bound. |
|
Definition
|
|
Term
NSAIDs undergo ____ metabolism and many are excreted as _____ conjugates. |
|
Definition
hepatic
glucuronide conjugates |
|
|
Term
NSAIDs have ____ half lives. |
|
Definition
Varying, some short, some long |
|
|
Term
In order to prevent the GI toxicity associated with NSAIDs, a ______ analog, ________ is used to prevent ulceration and bleeding by acting as a _______. |
|
Definition
Prostagalandin E analog
misoprostol (Cytotec)
H2 antagonist (proton pump inhibitor) |
|
|
Term
PGs are responsible for ______. |
|
Definition
Maintaining the integrity of the stomach |
|
|
Term
In addition to GI toxicity, NSAIDs are also associated with _____ toxicity. |
|
Definition
|
|
Term
Do hypersensitivities of NSAIDs exist? |
|
Definition
|
|
Term
Because of their high plasma protein binding and antiplatelet function, NSAIDs can _______ toxic effects. |
|
Definition
|
|
Term
NSAIDs can cause CNS effects of, _________ at _______. |
|
Definition
Dizziness, anxiety, tinnitus, and confusion
Large Doses (>>2 grams) |
|
|
Term
______ NSAID is associated with heaptic toxicity. |
|
Definition
|
|
Term
Acetaminophen is what class of NSAIDs? |
|
Definition
Para-aminophenol derivatives |
|
|
Term
Acetylsalicylic acid, (aspirin) serves as the prototype drug for the _______. |
|
Definition
|
|
Term
Acetylsalicylic acid, (aspirin) possesses functions of: _______ properties. |
|
Definition
analgesic, antipyretic, anti-inflammatory and antiplatelet |
|
|
Term
Aspirin (acetylsalicylic acid) is a weak organic ____ with a pKa of ___. |
|
Definition
|
|
Term
The breakdown of acetylsalicylic acid (Asprin) into _____ and _____ often leads to the ____-like odor of old aspirin tablets. |
|
Definition
acetic acid and salicylate
vinegar |
|
|
Term
Aspirin relieves _______ intensity pain such as headache, myalgia, arthralgia and other pains arising from integumental structures. |
|
Definition
|
|
Term
Aspirin ______ ______ body temperature. |
|
Definition
|
|
Term
Salicylates Antipyretic effect? |
|
Definition
An effective reset the "thermostat" |
|
|
Term
Salicylates Antipyretic mechanism? |
|
Definition
heat loss is enhanced as a result of cutaneous vasodilation and sweating |
|
|
Term
Salicylates do/don't reduce exercise-induced hyperthermia. |
|
Definition
|
|
Term
The salicylates are used in the treatment of _____ diseases, bc of their Anti-inflammatory Effects. |
|
Definition
|
|
Term
For salicylates, inhibition of ______ and _______ synthesis is the mechanism of anti-inflammatory action. |
|
Definition
prostaglandin
thromboxane |
|
|
Term
For salicylates, higher doses are required for effective _____ action, as compared to ________ doses. |
|
Definition
anti-inflammatory (Need higher to get COX-2)
analgesic and antipyretic |
|
|
Term
Aspirin does/doesn't inhibit the formation of leukotrienes via the lipoxygenase pathway. |
|
Definition
|
|
Term
The antiplatelet effect of aspirin comes _______. |
|
Definition
|
|
Term
Aspirin's Antiplatelet Effect significantly reduces the incidence of ______ and ______ in patients at risk |
|
Definition
stroke and myocardial infarction |
|
|
Term
At the lowest therapuetic doses, aspirin produces prolongation of _______, due to decreased ________. |
|
Definition
bleeding time
platelet aggregation |
|
|
Term
Aspirin covalently ______ a serine at the active site of platelet cyclooxygenase, thereby reducing the formation of _______ which promotes platelet aggregation. |
|
Definition
acetylates
thromboxane A2 |
|
|
Term
Salicylates _______ respiration directly and indirectly. |
|
Definition
|
|
Term
The direct stimulation by Salicylates on respiration is due primarily to an action on ______ which control rate. |
|
Definition
medullary respiratory neurons |
|
|
Term
Respiratory ______ nearly always occurs at some stage of salicylate poisoning due to the direct stimulation of respiration. |
|
Definition
|
|
Term
The indirect effect on respiration by Salicylates is due to salicylate-induced _____________. |
|
Definition
uncoupling of oxidative phosphorylation |
|
|
Term
High toxic doses of Salicylates _______ respiration. |
|
Definition
|
|
Term
If the toxic dose is high enough, the salicylates depress the medulla and cause ______ and ________. |
|
Definition
central respiratory paralysis and circulatory collapse (vasomotor depression) |
|
|
Term
With salicylates SEVERE toxicity can cause respiratory _______ and metabolic ________. |
|
Definition
|
|
Term
In infants and children, toxicity has usually developed beyond the initial phase of respiratory _____ before they are seen by the physician (respiratory _____ is then more commonly observed in children). |
|
Definition
|
|
Term
Dehydration may occur due to _______ through the lungs during hyperventilation and salicylate-induced ______. |
|
Definition
|
|
Term
________ is the main adverse effect associated with normal aspirin usage. |
|
Definition
|
|
Term
Salicylates may induce _____ and _____ due to stimulation of gastric mucosal receptors and stimulation of the medullary chemoreceptor trigger zone. |
|
Definition
|
|
Term
The mechanism of salicylate-induced gastric bleeding and damage also involves inhibition of _______ synthesis. |
|
Definition
|
|
Term
_____ & ________, which are inhibited by salicylates serve as cytoprotective agents in the gastric mucosa. |
|
Definition
|
|
Term
PGI2 and PGE2 serve as cytoprotective agents in the gastric mucosa by inhibiting _______, increasing ________, and enhancing __________. |
|
Definition
inhibit acid secretion, increase mucosal blood flow, and enhance secretion of protective gastric mucous. |
|
|
Term
______ excretion is altered by salicylates. |
|
Definition
|
|
Term
Low doses of salicylates (2 g or less) decrease urate excretion by _________. |
|
Definition
competing with urate for the organic acid secretory mechanism. |
|
|
Term
Inhibition of prostaglandin synthesis by salicylates can lead to decreased/increased renal blood flow. |
|
Definition
|
|
Term
In toxic doses (>>2 g per day), salicylates produce CNS _______, followed by ________. |
|
Definition
stimulation (including convulsions)
depression |
|
|
Term
Primary CNS symptoms of toxic doses of salicylates: ___________. |
|
Definition
dizziness, tinnitus, high tone deafness |
|
|
Term
Orally ingested salicylates are ______ absorbed, partly from the _____ and mostly from the _______. |
|
Definition
rapidly
stomach
small intestine |
|
|
Term
Salicylates rapidly distribute throughout the body, primarily by _______. |
|
Definition
pH-dependent passive diffusion. |
|
|
Term
Salicylate is _____ bound to plasma proteins. |
|
Definition
|
|
Term
Metabolism of salicylates takes place primarily in the liver ______ system and mitochondria. |
|
Definition
|
|
Term
The primary metabolites of salicylates are conjugates with _______ and ______ acid. |
|
Definition
glycine (salicyluric acid)
glucuronic (glucuronide) |
|
|
Term
Salicylate metabolism demonstrates _______ kinetics. |
|
Definition
|
|
Term
For Salicylates, at high and toxic doses metabolism occurs according to _____ order kinetics, while at lower doses metabolism proceeds according to ____ order kinetics |
|
Definition
|
|
Term
*The half-life for salicylate is _______ hours in low doses and ______ hours at high doses. |
|
Definition
3 to 6
15 to 30 (due to 0 order kinetics) |
|
|
Term
Salicylate is excreted in the _____ as the free compound and as ______. |
|
Definition
urine
conjugated metabolites |
|
|
Term
The amount of unchanged salicylate excreted may vary between 10% (_____ urine) and 85% (______ urine). |
|
Definition
|
|
Term
Excretion of the metabolites is pH _______. |
|
Definition
|
|
Term
_______ of the urine markedly enhance salicylate clearance. |
|
Definition
|
|
Term
Mild chronic salicylate intoxication occurring after repeated administration of high doses (>> 2g) is termed _______. |
|
Definition
|
|
Term
In severe toxic overdoes of salicylates _____thermia is usually present and dehydration often occurs. |
|
Definition
|
|
Term
Treatment of severe salicylate poisoning must be _______. |
|
Definition
|
|
Term
For severe salicylate poisoning, gastric lavage or induction of emesis will prevent further absorption if performed within a reasonable time after ingestion. ______ may be given to adsorb drug left in the stomach. |
|
Definition
|
|
Term
An association exists between the administration of aspirin to children with __________ and concomitant development of _______ with severe ______ and ______. |
|
Definition
acute febrile illness (influenza and chicken pox)
Reye's syndrome
severe hepatic injury and encephalopathy |
|
|
Term
|
Definition
|
|
Term
Acetaminophen (Tylenol) is an alternative to aspirin for ______ and ______ properties |
|
Definition
analgesic and antipyretic |
|
|
Term
Acetaminophen (Tylenol) is ineffective as a ________agent and is not considered useful as sole long-term therapy in _______. |
|
Definition
anti-inflammatory
rheumatic disease |
|
|
Term
Acetaminophen, in acute overdosage, acetaminophen can cause fatal _____. |
|
Definition
|
|
Term
Unlike asprin Acetaminophen produces little or no effect on: ________. |
|
Definition
respiration, cardiovascular function, acid-base balance, platelet aggregation, or uric acid excretion, gastric irritation, erosion and bleeding characteristic of aspirin. |
|
|
Term
Acetaminophen's half life is ______. |
|
Definition
|
|
Term
Acetaminophen's metabolism occurs by way of liver microsomal enzymes primarily by __________. |
|
Definition
the conjugating of glucuronic acid and sulfuric acid (as opposed to glycine with asprin). |
|
|
Term
In acute overdose, acetaminophen produces a dose-_______, potentially fatal_______. |
|
Definition
dependent
hepatic necrosis |
|
|
Term
Normally, acetaminophen is conjugated either as a ______ or a _______. |
|
Definition
|
|
Term
Normally, acetaminophen is conjugated either as a sulfate or a glucuronide, but with toxic doses, this system is ______ and microsomal enzymes produce other metabolites which can bind _______ groups on cell constituents. |
|
Definition
|
|
Term
The toxic metabolites the build up following acute overdose or acetaminophen are normally inactivated by ______. |
|
Definition
|
|
Term
If glutathione stores are depleted by large amounts of metabolites resulting from toxic doses of acetaminophen, then ______ damage ensues. |
|
Definition
|
|
Term
The hepatotoxicity caused by acetaminophen is immediate/delayed. |
|
Definition
|
|
Term
In toxic overdose of acetaminophen, GI symptoms reside _____ hours after ingestion. However, after _____ hours, hepatic enzymes, bilirubin, and prothrombin time become abnormal as hepatic injury occurs. |
|
Definition
|
|
Term
Protection against hepatic damage from acetaminophen overdose may be obtained by early administration of _____ compounds, ________ (________drug name) to inactivate the toxic metabolites. |
|
Definition
sulfhydryl
N-Acetylcysteine (Mucomyst, Mucosol) |
|
|
Term
N-Acetylcysteine (Mucomyst, Mucosol) is effective if given less than ____ hours after ingestion of toxic doses of acetaminophen. |
|
Definition
|
|
Term
Naproxen, an NSAID is unique in that it has a _______. |
|
Definition
|
|
Term
__________ (_________), is a new class of NSAIDs that are COX-2 SELECTIVE AGENTS. |
|
Definition
|
|
Term
Celecoxib exhibits ______ activity. |
|
Definition
anti-inflammatory, antipyretic, and analgesic activity |
|
|
Term
The mechanism of action of Celecoxib is inhibition of ______ synthesis, primarily via inhibition of __________. |
|
Definition
prostaglandin (Not TX also)
cyclooxygenase-2 |
|
|
Term
Celecoxib does not inhibit the cyclooxygenase-_ isoenzyme. |
|
Definition
|
|
Term
Clinical trials indicate that Celecoxib appears to be as effective as other NSAIDS in treating _______ and ______. |
|
Definition
osteoarthritis and rheumatoid arthritis |
|
|
Term
In short-term studies, celecoxib caused significantly fewer _______ than other NSAIDS and did not increase _______, consistent with a lack of COX-1 inhibition. |
|
Definition
gastrointestinal ulcers
bleeding time |
|
|
Term
Celecoxib is ___% bound to protein |
|
Definition
|
|
Term
Celecoxib is metabolized hepatically by _________. |
|
Definition
|
|
Term
Celecoxib metabolites are excreted in _______. |
|
Definition
|
|
Term
Celecoxib half life: ______. |
|
Definition
|
|
Term
Main adverse effect of Celecoxib? |
|
Definition
Prothrombotic effect: may increase the chance for MI in certain patients. |
|
|
Term
THERAPEUTIC INDEX = _____. |
|
Definition
|
|
Term
|
Definition
|
|
Term
ANTAGONISM example: _______ |
|
Definition
BACTERIOSTATIC + BACTERICIDAL |
|
|
Term
Exception to the antagonism of BS + BC: ________. |
|
Definition
***PENICILLILN + CLINDAMYCIN |
|
|
Term
ANTIBIOTIC COMBINATIONS advantages:_______. |
|
Definition
ENHANCE THERAPEUTIC (MUTATION): TB
DELAY RESISTANCE RELATED TOXICIT
DECREASE DOSE RELATED TOXICITY |
|
|
Term
AMINOGLYCOSIDE + _________ can enhance be used to enhance cell penetration and extension to gram +. |
|
Definition
|
|
Term
ERYTHROMYCIN spectrum: _______. |
|
Definition
|
|
Term
AMINOGLYCOSIDES spectrum: _______. |
|
Definition
- (+ also if combined with low dose penicillin) |
|
|
Term
CLINDAMYCIN spectrum: _______. |
|
Definition
|
|
Term
TETRACYCLINES spectrum: _______. |
|
Definition
|
|
Term
CHLORAMPHENICOL spectrum: _______. |
|
Definition
|
|
Term
NATURAL (INTRINSIC) RESISTANCE types: ________. |
|
Definition
NON - SUSCEPTIBLE METABOLISM
DESTROYS DRUG (ex. PENICILLINASE)
INABILITY OF DRUG TO PENETRATE |
|
|
Term
Example of NON - SUSCEPTIBLE METABOLISM, NATURAL (INTRINSIC) RESISTANCe? |
|
Definition
FOLIC ACID AS PRE - FORMED VITAMIN |
|
|
Term
ACQUIRED RESISTANCE types: _______. |
|
Definition
MUTATION ADAPTATION: BIOCHEMICAL INDUCTION (LOW DOSE) INFECTIOUS DRUG RESISTANCE |
|
|
Term
INFECTIOUS DRUG Aquired RESISTANCE sources: _______. |
|
Definition
*R – FACTORS: CONJUGATION
BACTERIOPHAGES – TRANSDUCTION
TRANSPOSITION |
|
|
Term
Conjugation Resistance is a big factor for __________. |
|
Definition
|
|
Term
|
Definition
|
|
Term
SUPERINFECTION DEF: ___________ |
|
Definition
REPLACEMENT (NEW) INFECTION |
|
|
Term
CELEBREX (NSAID) is a ______ drug. So if you are allergic to it you will be sensitive to ______. |
|
Definition
Sulfa (-SO2-NH)
Sulfonamides |
|
|
Term
Two main antibiotic missuses: ________. |
|
Definition
*UNTREATABLE INFECTIONS (VIRUS)
*FEVER OF UNDETERMINED ORIGIN |
|
|
Term
SULFONAMIDES chemical group _______. |
|
Definition
|
|
Term
SULFONAMIDE derivatives are made by attaching an R group to ______. |
|
Definition
|
|
Term
No change in the ______ of SULFONAMIDES is tolerated. |
|
Definition
|
|
Term
If the NH2 group of the other end of SULFONAMIDES (opposite of the SO2-NH2) is replaced by COOH, H, OH, alkyll ______. |
|
Definition
|
|
Term
Original SULFANILAMIDE drug (2 SULFANILAMIDEs linked): _______. |
|
Definition
PRONTOSIL (not used anymore) |
|
|
Term
PRONTOSIL is a _____ drug and must be ______. |
|
Definition
pro
metabolized to active form |
|
|
Term
PRONTOSIL is a prodrug that is metabolized into its active metabolite by _______, which cleaves _______ to release ________. |
|
Definition
Liver
The double bond between the two Nitrogen groups to release two molecules of sulfanilmide |
|
|
Term
SULFANILAMIDEs are _______ inhibitors of ________. |
|
Definition
competitive
PABA (para-Aminobenzoic Acid) |
|
|
Term
Sulfanilamides adhere to ________, the ________ concept. |
|
Definition
WOODS - FILES THEORY
ANTIMETABOLITE CONCEPT |
|
|
Term
Sulfanilamides disrupt metabolic pathways by mimicking ______. |
|
Definition
|
|
Term
In order for Sulfanilamides to inhibit growth the organism must: ______. |
|
Definition
Not absorb FA (Folic Acid) Not require an external source (FA) Synthessize FA |
|
|
Term
Sulfanilamides blocks the incorporation of _______ by the _______ enzyme. |
|
Definition
|
|
Term
COUPLING enzyme aka ____________. |
|
Definition
|
|
Term
RESISTANCE TO THE Sulfanilamides mechanisms: __________. |
|
Definition
1) DECREASED PERMEABILITY AND TRANSPORT 2) GENETIC CHANGES: COUPLING ENZYME (decreased affinity for Sulfanilamides and increased affinity for PABA) 3) Increased PRODUCTION OF PABA |
|
|
Term
There exists different _______ of Folic Acid. |
|
Definition
|
|
Term
In addition to different oxidation states ,different ______ can be linked to _______. |
|
Definition
|
|
Term
REACTIONS INVOLVING FH4: __________. |
|
Definition
Purine synthesis Thymine synthesis* Methionine synthesis* Serine synthesis |
|
|
Term
Sulfanilamides distribution: ________. |
|
Definition
ALL TISSUES: PLEURAL, PERITONEAL, SYNOVIAL, OCULAR FLUIDS, CSF |
|
|
Term
Sulfanilamides: ______ plasma proteins. |
|
Definition
|
|
Term
What is active, bound or free drug? |
|
Definition
|
|
Term
Sulfanilamides excretion: ________. |
|
Definition
|
|
Term
Sulfanilamides T1/2 is dependent on ______. |
|
Definition
|
|
Term
For Sulfanilamides, does kidney function affect dosage? |
|
Definition
Yes, decrease with disease |
|
|
Term
Sulfanilamides is metabolized by the _________ by ________. |
|
Definition
|
|
Term
Sulfanilamides once acetylated in the liver _______ function and ______ toxic potential. |
|
Definition
loses biological function but maintains toxic potenital |
|
|
Term
Sulfanilamides solubility ______ in acidic urine and ______ in alkaline urine. |
|
Definition
|
|
Term
A rare problem associated with Sulfanilamides and the kidneys is _________. |
|
Definition
CRYSTALLURIA HEMATURIA OBSTRUCTION |
|
|
Term
CRYSTALLURIA HEMATURIA OBSTRUCTION following Sulfanilamides admin is treated with ________. |
|
Definition
|
|
Term
TRISULFAPYRIMIDINES is a TRIPLE SULFONAMIDE and gets around the solubility issue with CRYSTALLURIA HEMATURIA OBSTRUCTION by _______. |
|
Definition
Combining 3 sulfa drugs so to lower their individual doses |
|
|
Term
SULFONAMIDE main complication: ________. |
|
Definition
|
|
Term
HEMATOLOGICAL complications can arise from Sulfanilamides because _______. |
|
Definition
if a patient is deficient in G6PDH, there will be an increase in hemolytic reactions and anemia, bc they cannot reduce the GLUTATHIONE necessary for RBC structure. |
|
|
Term
A rare, .1% side effect of Sulfanilamides is ________, resulting in ________. |
|
Definition
AGRANULOCYTOSIS
LEUKOPENIA |
|
|
Term
Sulfanilamides can cause hemolysis because they are ______ drugs and ______ GLUTATHIONE. |
|
Definition
|
|
Term
Acetylation of Sulfanilamides makes them more or less soluble, and therefore ________ CRYSTALLURIA. |
|
Definition
|
|
Term
Best way to prevent CRYSTALLURIA with Sulfanilamides is to __________. |
|
Definition
|
|
Term
Sulfanilamides have ______ half lives. |
|
Definition
|
|
Term
Because of their long half lives, Sulfanilamides, can have ________, which is characterized as ________. |
|
Definition
STEVENS - JOHNSON SYNDROME
a HYPERSENSITIVITY RX, with ERYTHEMA, MULTIFORME, and BLISTERING OF MUCOUS MEMBRANES |
|
|
Term
Sulfanilamides have GI complications of __________, resulting from __________. |
|
Definition
bowel bleeding
Reduced Vitamin K synthesis, required for the prothrombin factors, VII IX and X, the Sulfanilamides kill off the Vit K synthesizing bacteria of the bowel. |
|
|
Term
Sulfonamides have a drug interaction with ______ in neonates where it ______. |
|
Definition
Bilirubin
displaces the bilirubin bound, called KERNICTERUS |
|
|
Term
Bc of its high plasma binding Sulfonamides can elicit a __________ effect by displacing ____________, decreasing ______ synthesis, and inhibiting ________ metabolism. |
|
Definition
HYPOPROTHROMBINEMIC
BOUND WARFARIN
Vit K
Warfin |
|
|
Term
Sulfonamides displace ______ drug and therefore its doses need to be lowered. |
|
Definition
|
|
Term
Sulfonamides increase the half life of _______, by competing for _______. |
|
Definition
PHENYTOIN
Microsomal enzymes of the liver for metabolism |
|
|
Term
Phenytoin- anti seizure medicine WIKI
half life increased by Sulfonamides |
|
Definition
|
|
Term
______ is an NSAID that has a sulfa group and therefore has cross reactivity with individuals who are allergic to Sulfonamides |
|
Definition
|
|
Term
|
Definition
|
|
Term
***Primary use of Sulfonamides? |
|
Definition
combined with TRIMETHOPRIM to treat UTI |
|
|
Term
Sulfonamides used to treat: __________. |
|
Definition
*NOCARDIOSIS
*Shigella
*Chlamydia
*PNEUMOCYTIS JIROVECI (pneumonia)
*TOXOPLASMA |
|
|
Term
Sulfanilamides solubility ______ in acidic urine and ______ in alkaline urine. |
|
Definition
|
|
Term
A rare problem associated with Sulfanilamides and the kidneys is _________. |
|
Definition
CRYSTALLURIA HEMATURIA OBSTRUCTION |
|
|
Term
CRYSTALLURIA HEMATURIA OBSTRUCTION following Sulfanilamides admin is treated with ________. |
|
Definition
|
|
Term
TRISULFAPYRIMIDINES is a TRIPLE SULFONAMIDE and gets around the solubility issue with CRYSTALLURIA HEMATURIA OBSTRUCTION by _______. |
|
Definition
Combining 3 sulfa drugs so to lower their individual doses |
|
|
Term
SULFONAMIDE main complication: ________. |
|
Definition
|
|
Term
HEMATOLOGICAL complications can arise from Sulfanilamides because _______. |
|
Definition
if a patient is deficient in G6PDH, there will be an increase in hemolytic reactions and anemia, bc they cannot reduce the GLUTATHIONE necessary for RBC structure. |
|
|
Term
A rare, .1% side effect of Sulfanilamides is ________, resulting in ________. |
|
Definition
AGRANULOCYTOSIS
LEUKOPENIA |
|
|
Term
Sulfanilamides can cause hemolysis because they are ______ drugs and ______ GLUTATHIONE. |
|
Definition
|
|
Term
Acetylation of Sulfanilamides makes them more or less soluble, and therefore ________ CRYSTALLURIA. |
|
Definition
|
|
Term
Best way to prevent CRYSTALLURIA with Sulfanilamides is to __________. |
|
Definition
|
|
Term
Sulfanilamides have ______ half lives. |
|
Definition
|
|
Term
Because of their long half lives, Sulfanilamides, can have ________, which is characterized as ________. |
|
Definition
STEVENS - JOHNSON SYNDROME
a HYPERSENSITIVITY RX, with ERYTHEMA, MULTIFORME, and BLISTERING OF MUCOUS MEMBRANES |
|
|
Term
Sulfanilamides have GI complications of __________, resulting from __________. |
|
Definition
bowel bleeding
Reduced Vitamin K synthesis, required for the prothrombin factors, VII IX and X, the Sulfanilamides kill off the Vit K synthesizing bacteria of the bowel. |
|
|
Term
The Sulfonamide, Sulfasalazine is used to treat ________ & _________. |
|
Definition
ULCERATIVE COLITIS
RHEUMATOID ARTHRITIS |
|
|
Term
The Sulfonamide, Sulfasalazine is used to treat ULCERATIVE COLITIS using the _______ component and to treat RA using the ________ component. |
|
Definition
|
|
Term
Sulfasalazine has an antiinflammatory component, ___________. |
|
Definition
5 -AMINOSALICYLIC ACID (5-ASA) |
|
|
Term
Sulfasalazine is split at its _____ bond into two active components, _______ & ______. |
|
Definition
DIAZO BOND (double bond between two N's)
SULFAPYRIDINE & 5-AMINOSALICYLIC ACID |
|
|
Term
Sulfonamides are administered _______. |
|
Definition
|
|
Term
**Sulfonamides have a synergestic effect with __________. |
|
Definition
|
|
Term
All Sufa agents risk the development of ______ syndrome, especially those with _____, such as _______. |
|
Definition
STEVENS – JOHNSON SYN
long half lives
SULFADOXINE |
|
|
Term
FH4 is used in the conversion of ______ to _____ for DNA synthesis. |
|
Definition
Uracil to Thymidine
(dUMP to dTMP) |
|
|
Term
A methyl group from FH4 is required for the activation of ________, which is responsible for the __________. |
|
Definition
METHIONINE-tRNAF (inactive) -> FORMYL METHIONINE-tRNAF (active)
Initiation of protein synthesis |
|
|
Term
________ is an example of a large molecule antifolate. |
|
Definition
|
|
Term
Methotrexate's effect is due to the ________ theory. |
|
Definition
|
|
Term
Methotrexate is too ______ to be used as a __________. |
|
Definition
|
|
Term
Methotrexate can be used in acute high doses to be used as a ________ agent and treat: _______. |
|
Definition
Antineoplastic agent
- ACUTE LYMPHOCYTIC LEUKEMIA – CHORIOCARCINOMA - BURKITT’S LYMPHOMA |
|
|
Term
Methotrexate can be used in low dose chronic for treating: __________. |
|
Definition
PSORIASIS / R. ARTHRITIS
IMMUNOSUPPRESSION |
|
|
Term
METHOTREXATE toxicity ______. |
|
Definition
|
|
Term
High doses of METHOTREXATE used for cancer treatment toxicities: ________. |
|
Definition
**GI ulcers **BONE MARROW DEPRESSION **NEPHROTOXICITY |
|
|
Term
High doses of METHOTREXATE used for cancer treatment can be fatal, unless treated with the antidote, ______. |
|
Definition
|
|
Term
Low doses of METHOTREXATE used for RA/PSORIASIS & Immunosuppresion treatment toxicities: ________. |
|
Definition
**LIVER (HEPATIC FIBROSIS / CIRRHOSIS) *LUNG (PNEUMONITIS - RARE) **BONE MARROW / GI (ulcers) = RAPIDLY DIVIDING CELLS |
|
|
Term
Chronic METHOTREXATE treatment is supplemented with _______. |
|
Definition
|
|
Term
Acute METHOTREXATE treatment is supplemented with _______. |
|
Definition
|
|
Term
Two classes of Small Molecule Antifolates: __________. |
|
Definition
ANTI-MALARIAL- Pyrimethamine & Chloroguanide
ANTI-BACTERIAL- Trimethoprim |
|
|
Term
SMALL MOLECULE ANTIFOLATES serve as ______. |
|
Definition
|
|
Term
SMALL MOLECULE ANTIFOLATES' spectrum is decided by __________. |
|
Definition
|
|
Term
SMALL MOLECULE ANTIFOLATES act as ANTIBACTERIAL agents through their ________. |
|
Definition
Inhibition of FOLATE REDUCTASE |
|
|
Term
Chloroguanide is a _______ drug that must be __________. |
|
Definition
Small Molecule Antifolate antimalrial pro drug
be metablized into its cyclic form to become active |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
DIHYDROFOLATE REDUCTASE uses ______ to reduce F or FH2. |
|
Definition
|
|
Term
Large molecule antifolates act at ____________. |
|
Definition
|
|
Term
Small molecule antifolates act at ____________. |
|
Definition
|
|
Term
Trimethroprim is a _______ type of drug and is good against _______. |
|
Definition
Small molecule antifolate
Bacteria |
|
|
Term
Methotrexate is a _______ type of drug and is good against _______. |
|
Definition
Large molecule antifolate
Humans |
|
|
Term
Pyrimethamine is a _______ type of drug and is good against _______. |
|
Definition
Small molecule antifolate
Malria |
|
|
Term
The addition of _______ on Antifolates cause their inhibition of DIHYDROFOLATE REDUCTASE to _______. |
|
Definition
HYDROPHOBIC SIDECHAINS
Increase |
|
|
Term
Main toxicity of small molecule antifolates: __________. |
|
Definition
|
|
Term
Which of the small molecule antifolates, cause MEGALOBLASTIC ANEMIA? |
|
Definition
PYRIMETHAMINE
TRIMETHOPRIM |
|
|
Term
What are less toxic, large or small molecule antifolates? |
|
Definition
|
|
Term
BACTERIAL RESISTANCE against small molecule antifolate arises from? |
|
Definition
INCREASE IN FOLATE REDUCTASE |
|
|
Term
Sulfas prevent FH4 synthesis by ______. |
|
Definition
|
|
Term
Antifolates prevent FH4 synthesis by ________. |
|
Definition
binding dihydrofolate reductase |
|
|
Term
Synergestic effect occurs between Sulfas and________. |
|
Definition
Tyimethoprim (small molecule antifolate) |
|
|
Term
For Sulfa + Tyimethoprim (small molecule antifolate) _______ organ is important because _____. |
|
Definition
|
|
Term
Sulfa + Tyimethoprim (small molecule antifolate) toxicity: ________. |
|
Definition
**URINARY TRACT INFECTIONS *PROSTATITIS |
|
|
Term
In addition to Sulfa + Tyimethoprim, another synergistic effect exists for antimalarial- ________ + _______. |
|
Definition
PYRIMETHAMINE (Small Mol Antifolate)+ SULFADIAZINE |
|
|
Term
Inhibitors of DNA Synthesis: ______. |
|
Definition
QUINOLONES, FLUOROQUINOLONES |
|
|
Term
FLUOROQUINOLONES INHIBIT ________ OR ________. |
|
Definition
DNA GYRASE (TOPOISOMERASE II)
TOPOISOMERASE IV |
|
|
Term
FLUOROQUINOLONES types: ____________. |
|
Definition
–**CIPROFLOXACIN (CIPRO®) –**LEVOFLOXACIN (LEVAQUIN®) |
|
|
Term
Inhibition of _________ by FLUOROQUINOLONES targets gram -. |
|
Definition
TOPOISOMERASE II (DNA GYRASE) |
|
|
Term
Inhibition of _________ by FLUOROQUINOLONES targets gram +. |
|
Definition
|
|
Term
EUKARYOTIC CELLS -> NO _______ (with respect to FLUOROQUINOLONES). |
|
Definition
|
|
Term
FLUOROQUINOLONES are used in the treatment of: __________. |
|
Definition
*same as sulfa drugs *URINARY TRACT PATHOGENS *PROSTATITIS *SEXUALLY TRANSMITTED DISEASES *GI AND ABDOMINAL INFECTIONS *RESPIRATORY TRACT INFECTIONS (SERIOUS)
**BONE, JOINT AND SOFT TISSUE INFECTIONS ** Anthrax |
|
|
Term
Problem with FLUOROQUINOLONES use? |
|
Definition
Been used extensively in CHICKEN / CATTLE FEED |
|
|
Term
FLUOROQUINOLONES activity is decreased by _______. |
|
Definition
|
|
Term
*FLUOROQUINOLONES are metabolized by ________. |
|
Definition
|
|
Term
FLUOROQUINOLONES, ________ decrease absorption, because they _________. |
|
Definition
|
|
Term
FLUOROQUINOLONES toxicity: ______. |
|
Definition
**GI **CRYSTALLURIA (Rare) ** decrease CYT P450 ( therefore increase CAFFEINE, THEOPHYLLINE) ***TENDINITIS ***CARTILEGE DAMAGE |
|
|
Term
Because of the ***CARTILEGE DAMAGE associated with FLUOROQUINOLONES, FLUOROQUINOLONES are _________. |
|
Definition
Not recommended for CHILDREN / FETUS / PREGNANCY |
|
|
Term
URINARY ANTISEPTIC drug: ________. |
|
Definition
|
|
Term
NITROFURANTOIN excretion? |
|
Definition
|
|
Term
NITROFURANTOIN have no ________. |
|
Definition
|
|
Term
NITROFURANTOIN is only used to treat ________. |
|
Definition
CHRONIC LOWER URINARY TRACT INFECTIONS |
|
|
Term
NITROFURANTOIN is administered in ______. |
|
Definition
for MONTHS (14 DAY INTERVALS) |
|
|
Term
NITROFURANTOIN are not to be used for individuals that _________. |
|
Definition
Have severe renal insufficiency |
|
|
Term
NITROFURANTOIN spectrum: _______. |
|
Definition
Broad, many +/- but not P. AERUGINOSA, PROTEUS |
|
|
Term
NITROFURANS side effects: ________. |
|
Definition
**GASTROINTESTINAL EFFECT HEMATOLOGICAL REACTIONS (HEMOLYTIC ANEMIA – if low in G6PDH) |
|
|
Term
Three main FLUOROQUINOLONES side effects: _______. |
|
Definition
**GASTROINTESTINAL EFFECTS **DAMAGE TO GROWING CARTILAGE ***TENDINITIS -> TENDON RUPTURE |
|
|
Term
PENICILLIN structure is two rings: ________. |
|
Definition
Beta-Lactam Ring
Thiazolidine Ring |
|
|
Term
PENICILLIN acidic or basic? |
|
Definition
|
|
Term
Penicillins are formed by _______> |
|
Definition
Adding R groups to the NH2 of 6-aminopenicillanic acid |
|
|
Term
PENICILLIN R group determines: ________. |
|
Definition
– ANTIBACTERIAL SPECTRUM – ACID STABILITY – STABLE TO LACTAMASE |
|
|
Term
PENICILLIN G's problem of a short T1/2 was because it _______. |
|
Definition
Was rapidly cleared by the kidneys |
|
|
Term
PENICILLIN G's short half life was solved by _________. |
|
Definition
Combining it with another acid to decrease its excretion |
|
|
Term
PENICILLIN G's short half life was solved by Combining it with ______ or ________ to decrease its excretion. |
|
Definition
PROBENECID (increases urate excretion for gout treatment) |
|
|
Term
PENICILLIN G ACID INSTABILITY made it unable to be ________. |
|
Definition
|
|
Term
PENICILLIN G's ACID INSTABILITY problem was solved by the addition of ______. |
|
Definition
The addition of oxygen to its R group, PHENOXYACETIC ACID |
|
|
Term
PENICILLIN G's problem of penicillin resistant staph was solved by _______. |
|
Definition
Adding a different R group and forming METHICILLIN |
|
|
Term
PENICILLIN G's problem of a narrow spectrum (gram +) was solved by the addition of new R groups and formation of _______ and _______. |
|
Definition
|
|
Term
_______ formed from Penicillin in the presence of ________, is used to treat Copper-Wilson;s disease. |
|
Definition
β – β - DIMETHYL CYSTEINE
Strong H+ |
|
|
Term
When PENICILLIN's beta lactam ring is broken it forms ______ and gains a free _______, which can react with _______ to form ________. |
|
Definition
PENICILLOIC ACID
FREE -COOH
Lysine on proteins
HAPTEN |
|
|
Term
HAPTEN formation is an _________. |
|
Definition
|
|
Term
PENICILLINS ARE toxicity? |
|
Definition
PENICILLINS ARE REMARKABLY NONTOXIC |
|
|
Term
Although Penicillins may be relatively non-toxic they are relatively prone to __________. |
|
Definition
HYPERSENSITIVITY (10-15%) |
|
|
Term
Lethal component of Penicillin HYPERSENSITIVITY? |
|
Definition
|
|
Term
IMMEDIATE REACTION of HYPERSENSITIVITY to Penicillin occurs when? and is characterized as? |
|
Definition
Within MINUTES
REAL SERIOUS |
|
|
Term
ACCELERATED REACTION of HYPERSENSITIVITY to Penicillin occurs when? and is characterized as? |
|
Definition
30 MINUTES – 48 HOURS (FLUSH, ITCH) |
|
|
Term
DELAYED REACTION of HYPERSENSITIVITY to Penicillin occurs when? and is characterized as? |
|
Definition
SEVERAL DAYS TO SEVERAL WEEKS (ITCH, JOINT PAIN, FEVER) |
|
|
Term
TREATMENT OF SEVERE penicillin HYPERSENSITIVITY REACTIONS: _______. |
|
Definition
**EPINEPHRINE *DIPHENHYDRAMINE |
|
|
Term
ANAPHYLAXIS of HYPERSENSITIVITY REACTIONS symptoms: _________. |
|
Definition
–***SUDDEN, SEVERE HYPOTENSION –***RAPID DEATH –***BRONCHOCONSTRICTION –***SEVERE ASTHMA |
|
|
Term
Narrow Spectrum Penicillins that are Gram +: ________. |
|
Definition
Penicillin G and Penicillin V |
|
|
Term
Beta Lactamase RESISTANT PENICILLINS: _________. |
|
Definition
OXACILLIN NAFCILLIN DICLOXACILLIN |
|
|
Term
Problem with the Beta Lactamase RESISTANT PENICILLINS (OXACILLIN, NAFCILLIN, DICLOXACILLIN) |
|
Definition
|
|
Term
BROAD SPECTRUM PENICILLIN, _________ aka the amino penicilins. |
|
Definition
AMPICILLIN
AMINO penicillins |
|
|
Term
AMPICILLIN is a broad spectrum penicillin, bc unlike other penicillins it covers gram __ also. |
|
Definition
|
|
Term
The broad spectrum penicillin, AMPICILLIN, is not active against _______ & ______. |
|
Definition
–**PSEUDOMONAS –**KLEBSIELLA |
|
|
Term
Broad spectrum Penicillins: __________. |
|
Definition
AMPICILLIN AMOXICILLIN BACAMPICILLIN TICARCILLIN PIPERACILLIN |
|
|
Term
The broad spectrum penicillins disadvantage, __________. |
|
Definition
inactivated by β - LACTAMASES |
|
|
Term
BACAMPICILLIN, the broad spectrum penicillin, works by ______. |
|
Definition
freeing AMPICILLIN, broad spectrum, after ingestion |
|
|
Term
PIPERACILLIN & TICARCILLIN are used to treat ______ and _____, or just serious gram ___ infections. |
|
Definition
*EXCELLENT FOR PSEUDOMONAS **PICK UP KLEBSIELLA
- |
|
|
Term
Pseudomonas aeruginosa is treated using combination drug therapy of _______ or _______ + an _______ or _______. |
|
Definition
TICARCILLIN OR PIPERACILLIN (broad spectrum pencillins)
AMINOGLYCOSIDE OR FLUOROQUINOLONE |
|
|
Term
PENICILLINS target the last enzyme in _______. |
|
Definition
|
|
Term
|
Definition
|
|
Term
D - CYCLOSERINE interferes with _______ by ________. |
|
Definition
cell wall synthesis
inhibiting Racemase and ligase preventing the formation of D-alanine-D-alanine |
|
|
Term
In order to form the D- ALANYL – D – ALANINE from L - ALANINE for bacterial cell walls, two enzymes are used: ________. |
|
Definition
|
|
Term
D - CYCLOSERINE is used for _______. |
|
Definition
|
|
Term
Pencillin inhibits the __________ reaction between _______ and _____ of cell wall synthesis. |
|
Definition
TRANSPEPTIDATION REACTION
D - ALANINE and GLYCINE |
|
|
Term
Pencillin can inhibit the TRANSPEPTIDATION REACTION of gram_ bacteria. |
|
Definition
|
|
Term
Pencillin inhibits the transpeptidase reaction by _______. |
|
Definition
forming covalently bond to the enzyme |
|
|
Term
PENICILLIN inhibits the transpeptidase reaction by mimicking _________. |
|
Definition
|
|
Term
In addition to binding and inhibting the transpeptidase reaction, penicillin also binds ________ and activates _______. |
|
Definition
PENICILLIN – BINDING PROTEINS
AUTOLYTIC ENZYMES |
|
|
Term
β-LACTAMASE is located where for Gram +? |
|
Definition
|
|
Term
β-LACTAMASE is located where for Gram -? |
|
Definition
Between wall and membrane |
|
|
Term
If penicillin binds PENCILLIN BINDING PROTEINS ________, it leads to _______. |
|
Definition
ACTIVATION OF AUTOLYTIC ENZYMES & INHIBITION of PEPTIDOGLYCAN SYNTHESIS |
|
|
Term
CEPHALOSPORINS are similar in structure to _______. |
|
Definition
|
|
Term
Advantage of CEPHALOSPORINS over Penicillins? |
|
Definition
**LESS SUSCEPTIBLE TO PENICILLINASE |
|
|
Term
CEPHALOSPORINS have a _______ spectrum. |
|
Definition
|
|
Term
CEPHALOSPORINS have a broad spectrum and are used especially to treat ______, _____, and ______ |
|
Definition
– *PROTEUS (Broad Spectrum Penicillins innefective) – *E. COLI (Broad Spectrum Penicillins innefective) – *KLEBSIELLA |
|
|
Term
CEPHALOSPORINS mechanism of action? |
|
Definition
|
|
Term
Problem with the second generation of CEPHALOSPORINS? |
|
Definition
BLEEDING PROBLEMS & DISULFIRAM (nausea following drinking) both because the presence of (MTT = METHYL - TETRAZOLE - THIOMETHYL) |
|
|
Term
Each generation of CEPHALOSPORINS got better in which respect? |
|
Definition
|
|
Term
Cephalosporin, ________, demonstrates excellent _______ and is not _______. |
|
Definition
CEFEPIME
*EXCELLENT CSF LEVELS
HYDROLYSED BY β - LACTAMASES |
|
|
Term
CEFEPIME, a Cephalosporin, is used to treat: ___________. |
|
Definition
PSEUDOMONAS ENTEROBACTERIACEAE |
|
|
Term
In the third generation of Cephalosporins, they gained the ability to _______. |
|
Definition
|
|
Term
CEPHALOSPORINS are all potentially _____ toxic. |
|
Definition
|
|
Term
CEPHALOSPORINS are relatively non toxic, but should be cautious with _______ if ________. |
|
Definition
HYPERSENSITIVITY REACTIONS IF SEVERE RX TO PENICILLIN |
|
|
Term
CEPHALOSPORINS are _____ antibiotics. |
|
Definition
|
|
Term
In addition to CEPHALOSPORINS, ______ & ______ are also beta-lactam antibiotics. |
|
Definition
|
|
Term
The CARBAPENEM, Impienem, is a ______ inhibitor. |
|
Definition
Cell wall inhibitor (eta-lactam antibiotics) |
|
|
Term
The Carbapenem,Impienem, has ______ spectrum. |
|
Definition
|
|
Term
The Carbapenem, Impienem, is used to treat: ______ infections. |
|
Definition
URINARY TRACT / LOWER RESPIRATORY ABDOMINAL / GYN |
|
|
Term
The Carbapenem, Impienem, must be administered with _______, because it _________. |
|
Definition
Cilastatin decreases renal tubular dihydropeptidase, which normally destroys Carbapenem |
|
|
Term
The Carbapenem, Impienem, has a _____ with penicillin. |
|
Definition
|
|
Term
The Carbapenem, Meropenem, is similar to _______, but does not _______. |
|
Definition
Impienem
require Cilastatin |
|
|
Term
The Carbapenem, Meropenem side effect? |
|
Definition
Cross allergy with Penicillin
(Carbapenem, which are Beta Lactam Antibio) |
|
|
Term
Carbapenems (Impienem/Meropenem ) are used for ___________. |
|
Definition
Last resort therapy: E. COLI KLEBSIELLA PNEUMONIAE |
|
|
Term
Monobactams is a type of _______. |
|
Definition
|
|
Term
Monobactams are only used to treat _______. |
|
Definition
Only gram - rods (PSEUDOMONAS) |
|
|
Term
Monobactams like other Beta-lactam antibiotics are ________. |
|
Definition
Resistant to many β - LACTAMASES |
|
|
Term
Monobactams unique advantage over other Beta-lactam antibiotics? |
|
Definition
*CAN USE WITH PENICILLIN SENSITIVE PATIENT |
|
|
Term
Beta-Lactamase Inhibitors: ________. |
|
Definition
Clavulanate (Clavulanic Acid) Sulbactam Tazobactam |
|
|
Term
Beta-Lactamase Inhibitors are combined with ________. |
|
Definition
|
|
Term
Beta-Lactamase Inhibitors extend the coverage of Penicillins to ______. |
|
Definition
|
|
Term
Cycloserine is used to treat TB and it's MOA is inhibition of ________ and _______, leading to disruption of ______. |
|
Definition
Alanine Racemase
Alanine Ligase
Cell Wall Synthesis |
|
|
Term
Vancomycin, mechanism of action: ________, which disrupts _______. |
|
Definition
*BINDS D – ALA – D – ALA
Cell wall synthesis |
|
|
Term
Vancomycin used to treat ________, especially for _______ & ________. |
|
Definition
Gram +
MRSA, CLOSTRIDIUM DIFFICILE (Both Gram +) |
|
|
Term
Vancomycin can be _____toxic. |
|
Definition
|
|
Term
Vancomycin can cause __________ syndrome, which is _____________ and is caused by __________. |
|
Definition
RED MAN SYNDROME
*ERYTHEMATOUS, URTICARIA, *FLUSHING, *TACHCARDIA, HYPOTENSION
Histamine release from administered IV too quickly. |
|
|
Term
A major problem for Vancomycin resistance of is ________, which lead to ________ resistant bacteria. |
|
Definition
ALTERED D – ALA – D - ALA TARGET
VRSA (STAPH. AUREUS) |
|
|
Term
Vancomycin + _______ can have a synergestic effect on its Ototoxic property. |
|
Definition
|
|
Term
_______ is similar to Vancomycin and acts as a __________ inhibitor. |
|
Definition
Teicoplanin
Cell wall syntehsis inhibitor |
|
|
Term
Teicoplanin's main treatment use is for: __________. |
|
Definition
STEOMYELITIS, ENDOCARDITIS caused by Methicillin and Endocarditis caused by methicillin-resistant and methicillin-susceptible Staph, Strep, and Enterococci |
|
|
Term
Teicoplanin can be combined with ______ when treating S. Aureus. |
|
Definition
|
|
Term
Bacitracin disrupts _______, by inhibiting _______. |
|
Definition
Interferes with transport across the membrane for molecules to be used in cell wall synthesis. Therefore it is a membrane inhibitor not a cell wall inhibitor. |
|
|
Term
Bacitracin is used to treat ________ and ________. |
|
Definition
Staph
Gram + infections that have not responded to other treatments |
|
|
Term
Bacitracin can be administered Intrathecal/Intrapleurally to treat ________. |
|
Definition
Resistant Staph Meningitis/ Empyema (pus in the body cavity) |
|
|
Term
Bacitracin possess serious _______toxicity, especially when given with ___________ and when administered _______, but not when administered _____. |
|
Definition
Nephrotoxicity
AG
Parenteral
Orally |
|
|
Term
A clinical problem with Bacitracin is it becomes nephrotoxic if it ___________, therefore it is primarily administered ________. |
|
Definition
enter systemic circulation
Topically |
|
|
Term
Polymyxin B Sulfate is a _________ (overall structure). |
|
Definition
Cyclic Poplypeptide Antibitoic |
|
|
Term
Polymyxin B Sulfate is a ________ that disrupts ________. |
|
Definition
Cationic detergent
Cell membranes |
|
|
Term
Polymyxin B Sulfate is administered ______. |
|
Definition
|
|
Term
Polymyxin B Sulfate exhibits extreme ______toxicity when administered ________. |
|
Definition
|
|
Term
Polymyxin B Sulfate is used to treat _______ and ______. |
|
Definition
Resistant Gram -
Pseudomonas in CF |
|
|
Term
Colistin sulfate is a ________ that disrupts ________. |
|
Definition
Cationic detergent
Cell membranes |
|
|
Term
Colistin sulfate is used to treat ______. |
|
Definition
|
|
Term
Colistin sulfate toxicity? |
|
Definition
Non unless administered parenterally (not recommended) |
|
|
Term
Polymyxin B and Colistin Sulfate are old antibiotics that are being used to treat ________. |
|
Definition
Emerging multiresistant gram - |
|
|
Term
Vancomycin, mechanism of action: ________, which disrupts _______. |
|
Definition
*BINDS D – ALA – D – ALA
Cell wall synthesis |
|
|
Term
Vancomycin used to treat ________, especially for _______ & ________. |
|
Definition
Gram +
MRSA, CLOSTRIDIUM DIFFICILE (Both Gram +) |
|
|
Term
Vancomycin can be _____toxic. |
|
Definition
|
|
Term
Vancomycin can cause __________ syndrome, which is _____________ and is caused by __________. |
|
Definition
RED MAN SYNDROME
*ERYTHEMATOUS, URTICARIA, *FLUSHING, *TACHCARDIA, HYPOTENSION
Histamine release from administered IV too quickly. |
|
|
Term
A major problem for Vancomycin resistance of is ________, which lead to ________ resistant bacteria. |
|
Definition
ALTERED D – ALA – D - ALA TARGET
VRSA (STAPH. AUREUS) |
|
|
Term
Vancomycin + _______ can have a synergestic effect on its Ototoxic property. |
|
Definition
|
|
Term
_______ is similar to Vancomycin and acts as a __________ inhibitor. |
|
Definition
Teicoplanin
Cell wall syntehsis inhibitor |
|
|
Term
Teicoplanin's main treatment use is for: __________. |
|
Definition
STEOMYELITIS, ENDOCARDITIS caused by Methicillin and Endocarditis caused by methicillin-resistant and methicillin-susceptible Staph, Strep, and Enterococci |
|
|
Term
Teicoplanin can be combined with ______ when treating S. Aureus. |
|
Definition
|
|
Term
Bacitracin disrupts _______, by inhibiting _______. |
|
Definition
Interferes with transport across the membrane for molecules to be used in cell wall synthesis. Therefore it is a membrane inhibitor not a cell wall inhibitor. |
|
|
Term
Bacitracin is used to treat ________ and ________. |
|
Definition
Staph
Gram + infections that have not responded to other treatments |
|
|
Term
Bacitracin can be administered Intrathecal/Intrapleurally to treat ________. |
|
Definition
Resistant Staph Meningitis/ Empyema (pus in the body cavity) |
|
|
Term
Daptomycin is similar to ______ and is used to treat ______ and _______. |
|
Definition
VANCOMYCIN
VANCOMYCIN- resistant Enterococci & Staph. Aureus |
|
|
Term
Daptomycin's MofA: _______. |
|
Definition
Depolarizes membrane and causes K efflux |
|
|
Term
Daptomycin is an alternative for _____. |
|
Definition
|
|
Term
______ can diminish the effects of oral contraceptives. |
|
Definition
|
|
Term
|
Definition
|
|
Term
The incoming _______ binds at the Aminoacyl Site. |
|
Definition
|
|
Term
The peptide linkage is formed between the ____ and ____ site. |
|
Definition
|
|
Term
The peptide linkage between the P and A is catalyzed by _____ enzyme. |
|
Definition
|
|
Term
What is the name of the reaction when that follows the peptidyl transferase reaction and what happens? |
|
Definition
The translocation reaction
A site shifts to P side and next aminoacyl tRNA goes into A site |
|
|
Term
Erythromycin is a _______ type of antibiotic. |
|
Definition
|
|
Term
A macrolide antibiotic is a ______ structure with ______ attached. |
|
Definition
|
|
Term
3 macrolide antibiotics: ________. |
|
Definition
Erythromycin Clarithromycin Azithromycin |
|
|
Term
Erythromycin disrupts _______. |
|
Definition
|
|
Term
Erythromycin disrupts protein synthesis by ________. |
|
Definition
Inhibiting the incorporation of Amino Acids |
|
|
Term
Erythromycin binds to ________ in order to inhibit protein synthesis. |
|
Definition
|
|
Term
Erythromycin mainly inhibits the _____ step of protein synethesis. It also inhibits ______ (minor) and _______ by binding to ________. |
|
Definition
TRANSLOCATION STEP
Formation of initiation complex
Peptidyl Transferase by binding to 23S rRNA |
|
|
Term
Erythromycin static/cydial? |
|
Definition
|
|
Term
Erythromycin's activity is dependent upon? |
|
Definition
|
|
Term
Erythromycin's activity increases at _____pHs. |
|
Definition
|
|
Term
|
Definition
|
|
Term
In addition to Erythromycin's main targets of Gram +, what unique gram - can it also be used to treat? |
|
Definition
|
|
Term
The spectrum of Erythromycin is dependent upon ______. |
|
Definition
Penetration into the cell |
|
|
Term
Resistance to Erythromycin is through: __________. |
|
Definition
MUTATION – 50S (decrease binding)
EFFLUX BY ACTIVE PUMP
HYDROLYSIS OF MACROLIDES
INDUCED RESISTENCE – LOW DOSE |
|
|
Term
Resistance to Erythromycin is cross resistance with ______. |
|
Definition
|
|
Term
Why is the estolate form of Erythromycin no longer used? |
|
Definition
CHOLESTATIC HEPATITIS (10 - 12%) |
|
|
Term
The free/sterate form of Erythromycin's main side effect is _______. |
|
Definition
**Epigastric Distress (Nausea, Vomiting, diarrhea) |
|
|
Term
Erythromycin has good _______ and low ______ and becomes concentrated in _______. |
|
Definition
*GOOD BODY DISTRIBUTION *LOW IN CSF *CONCENTRATED IN LIVER |
|
|
Term
Erythromycin *H. PYLORI (PEPTIC ULCERS)is excreted __________. |
|
Definition
|
|
Term
Erythromycin is excreted in the bile in its _____ form, because it is _________ in the liver. |
|
Definition
bile
concentrated in the liver |
|
|
Term
_______ excretion is low in Ertyhtromycin. |
|
Definition
|
|
Term
Ertyhtromycin dosage for kidney disease? |
|
Definition
|
|
Term
Ertyhtromycin dosage for liver disease? |
|
Definition
same dose (unless severely damaged) |
|
|
Term
Ertyhtromycin is the drug of choice for: _______. |
|
Definition
Mycoplasma Pneumoniae Legionella Diphtheria |
|
|
Term
Ertyhtromycin can be used as a substitute for _________. |
|
Definition
|
|
Term
Ertyhtromycin can be used as a substitute for penicillin for those who are allergic for _______ & ______ infections. |
|
Definition
Strep infections
Staph infections |
|
|
Term
Clarithromycin is a _____ type of drug. |
|
Definition
|
|
Term
Clarithromycin is used to treat: __________. |
|
Definition
*H. INFLUENZE *MYCOBACTERIUM AVIUM (AIDS PATIENT) *H. PYLORI (PEPTIC ULCERS) |
|
|
Term
Azithromycin is a ______ type of drug. |
|
Definition
|
|
Term
Azithromycin is used to treat: __________. |
|
Definition
MYCOBACTERIUM AVIUM (AIDS) (Just like Clarithromycin)
TOXOPLASMOSIS ENCEPHALITIS (AIDS)
URETHRITIS (CHYLAMYDIA TRACHOMATIS) |
|
|
Term
Telithromycin is a macrolide that can be used to treat __________. |
|
Definition
COMMUNITY- ACQUIRED PNEUMONIA |
|
|
Term
Macrolide main drug drug interactive? |
|
Definition
Decrease the activity of CYT P450 Increase the activity of other drugs |
|
|
Term
Which macrolides decrease CYT P450 and which have no affect? |
|
Definition
Decrease: Clarithromycin Ertyhtromycin
AZITHROMYCIN |
|
|
Term
Erythromycin has good _______ and low ______ and becomes concentrated in _______. |
|
Definition
*GOOD BODY DISTRIBUTION *LOW IN CSF *CONCENTRATED IN LIVER |
|
|
Term
Erythromycin *H. PYLORI (PEPTIC ULCERS)is excreted __________. |
|
Definition
|
|
Term
Erythromycin is excreted in the bile in its _____ form, because it is _________ in the liver. |
|
Definition
bile
concentrated in the liver |
|
|
Term
_______ excretion is low in Ertyhtromycin. |
|
Definition
|
|
Term
Ertyhtromycin dosage for kidney disease? |
|
Definition
|
|
Term
Ertyhtromycin dosage for liver disease? |
|
Definition
same dose (unless severely damaged) |
|
|
Term
Ertyhtromycin is the drug of choice for: _______. |
|
Definition
Mycoplasma Pneumoniae Legionella Diphtheria |
|
|
Term
Ertyhtromycin can be used as a substitute for _________. |
|
Definition
|
|
Term
Ertyhtromycin can be used as a substitute for penicillin for those who are allergic for _______ & ______ infections. |
|
Definition
Strep infections
Staph infections |
|
|
Term
Clarithromycin is a _____ type of drug. |
|
Definition
|
|
Term
Clarithromycin is used to treat: __________. |
|
Definition
*H. INFLUENZE *MYCOBACTERIUM AVIUM (AIDS PATIENT) *H. PYLORI (PEPTIC ULCERS) |
|
|
Term
Azithromycin is a ______ type of drug. |
|
Definition
|
|
Term
Azithromycin is used to treat: __________. |
|
Definition
MYCOBACTERIUM AVIUM (AIDS) (Just like Clarithromycin)
TOXOPLASMOSIS ENCEPHALITIS (AIDS)
URETHRITIS (CHYLAMYDIA TRACHOMATIS) |
|
|
Term
Types of Lincosamides: _______. |
|
Definition
Clindamycin
Clindamycin Phosphate |
|
|
Term
Lincosamides (Clindamycin & Clindamycin Phosphate) disrupt? |
|
Definition
|
|
Term
Lincosamides (Clindamycin & Clindamycin Phosphate) bind? |
|
Definition
|
|
Term
Lincosamides (Clindamycin & Clindamycin Phosphate) have an antagonist relationship with ________. |
|
Definition
|
|
Term
Lincosamides (Clindamycin & Clindamycin Phosphate) block the ______ step of protein synthesis. |
|
Definition
|
|
Term
Lincosamides (Clindamycin & Clindamycin Phosphate) have a ______ spectrum? |
|
Definition
|
|
Term
Lincosamides (Clindamycin & Clindamycin Phosphate) have spectrum similar to ERYTHROMYCIN, _______, but in addition it also is useful for _______ infections. |
|
Definition
Broad Spectrum
**ANAEROBIC INFECTIONS |
|
|
Term
Lincosamides (Clindamycin & Clindamycin Phosphate) can be used to treat severe anaerobic infections, such as ________. |
|
Definition
–** BACTEROIDES (RESP STRAINS) –** BACTEROIDES (GI STRAINS) |
|
|
Term
Clindamycin has cross resistance with _______. |
|
Definition
ERYTHROMYCIN (both bind 50s and block the translocation step) |
|
|
Term
Clindamycin is metabolized by the __________. |
|
Definition
|
|
Term
Clindamycin is excreted by the _______. |
|
Definition
|
|
Term
Clindamycin dose if liver disease? |
|
Definition
|
|
Term
Clindamycin dose if kidney disease? |
|
Definition
|
|
Term
If poor kidney function, Clindamycin's ________. |
|
Definition
|
|
Term
Clindamycin's main toxicity? |
|
Definition
Selects for C. DIFFICILE and causes *PSEUDOMEMBRANEOUS ENTEROCOLITIS |
|
|
Term
Clindamycin's main toxicity is it selects for DIFFICILE and causes PSEUDOMEMBRANEOUS ENTEROCOLITIS, this can be treated with either _______ or _______. |
|
Definition
|
|
Term
Clindamycin is used for patients that are _________ and to treat ______. |
|
Definition
PENICILLIN (Just like ERYTHROMYCIN is)
Anaerobic infections |
|
|
Term
Clindamycin has an antagonist affect with _________. |
|
Definition
|
|
Term
Tetracyclines are _______ spectrum. |
|
Definition
|
|
Term
Tetracycline drugs: __________. |
|
Definition
|
|
Term
Tetracyclines bind ________ in order to distrupt. |
|
Definition
|
|
Term
Tetracycline inhibit the __________. |
|
Definition
Attachment of the amino-acyl tRNA to "A" site |
|
|
Term
Is there much difference between the spectrums of Tetracyclines? |
|
Definition
|
|
Term
Tetracylcine resistance is _______ mediated. |
|
Definition
|
|
Term
The main mechanisms of resistance against Tetracyclines is: __________. |
|
Definition
**+ENERGY – DEPENDENT increase in Efflux **RIBOSOME PROTECTION PROTEINS (can't reach ribosome) R+ Factor |
|
|
Term
Tetracylcine pharmokinetic drawback is __________, except for ________. |
|
Definition
Incomplete absorption
Doxycycline |
|
|
Term
Due to the incomplete absorption of Tetracylcines, complications: _______. |
|
Definition
1) *ERRATIC BLOOD LEVELS 2) *RESIDUAL IN GI TRACT -> NAUSEA / VOMITING / GI IRRITATION 3) *SUPERINFECTION |
|
|
Term
Tetracylcines' poor absorption can be partially attributed to _______, including: __________. |
|
Definition
CHELATORS
MILK PRODUCTS Iron ANTACIDS FOR ULCERS |
|
|
Term
Which Tetracyclines have long half life and which ones have short? |
|
Definition
Tetracycline short
Minocycline/Doxycycline Long |
|
|
Term
The Tetracyclines, DOXYCYCLINE / MINOCYCLINE, have a longer half life and thus a lower ________, than Tetracycline. |
|
Definition
|
|
Term
Tetracyclines can develop ______ toxicity which means you have to discontinue use. |
|
Definition
|
|
Term
In addition to GI toxicity, Tetracyclines have: ________ toxicities. |
|
Definition
PHOTOSENSITIVITY ONYCHOLYSIS (LOOSE NAILS) / PIGMENTATION OF THE NAILS *RENAL TOXICITY *TEETH: FLUORESCENCE DISCOLORATION *Bone: deformity DIZZINESS / VERTIGO – VESTIBULAR REACTIONS *SUPERINFECTION |
|
|
Term
The renal toxicity of Tetracyclines can cause __________, from the use of ________, which affects __________. |
|
Definition
Fanconi Syndrome
Outdated drugs
Proximal Tubules |
|
|
Term
In patients with impaired kidney function, Tetracyclines __________, except for _________ and ________. |
|
Definition
Accumulate
Minocycline/Doxycycline |
|
|
Term
Why do Tetracyclines accumulate in impaired kidneys, while Minocycline/Doxycycline do not? |
|
Definition
The have low renal clearence |
|
|
Term
Tetracyclines can have toxic effects on the teeth by causing ______ and ______. |
|
Definition
FLUORESCENCE DISCOLORATION |
|
|
Term
Because of their ______ toxicity Tetracyclines, are not recommended for use in ________. |
|
Definition
Bone (deformities)
Children |
|
|
Term
With _______ use, Tetracyclines can cause _______ superinfections. |
|
Definition
|
|
Term
Tetracyclines effect on teeth is ______ discoloration. |
|
Definition
|
|
Term
Tetracyclines static or cidal? |
|
Definition
|
|
Term
Tetracyclines should not be combined with? |
|
Definition
|
|
Term
Tetracyclines + ________ or ______ or _______ increases the metabolism of Tetracyclines and therefore __________. |
|
Definition
CARBAMAZEPINE PHENOBARBITAL PHENYTOIN (Anti EPILEPSY agents)
Reduces their half lives |
|
|
Term
Tetracylcines can diminish the effects of ________. |
|
Definition
Oral contraceptives (just like ampicillin) |
|
|
Term
Tetracylcines is the drug of choice for: _____________. |
|
Definition
Diseases caused by Rickettsia (RMSF) and Coxillea (Q Fever)
Lyme Disease (Borrelia) |
|
|
Term
Lyme Disease Stages: __________. |
|
Definition
– 1) ERYTHEMA MIGRANS (RASH) – 2) NEUROLOGIC DISEASE – 3) CARDIAC DISEASE – 4) ARTHRITIS |
|
|
Term
______ or ______ can be used to treat Lyme Disease. |
|
Definition
Doxycycline (Tetracylcine) or Amoxicillin |
|
|
Term
Tigecycline is a derivative of _______. |
|
Definition
|
|
Term
Tigecycline binds to _____. |
|
Definition
|
|
Term
Tigecycline binds to 30S and blocks _______. |
|
Definition
|
|
Term
|
Definition
|
|
Term
Tigecycline toxicities: ________. |
|
Definition
NAUSEA, VOMITING, PHOTOSENSITIVITY, ELEVATED SERUM AMYLASE, HYPERBILIRUBINEMIA, ELEVATED BUN |
|
|
Term
Tigecycline is not for use in __________. |
|
Definition
|
|
Term
Tigecycline is used to treat complicated ________ and ______ infections. |
|
Definition
|
|
Term
Tigecycline's main use is to treat _______. |
|
Definition
where other drugs have not been successful |
|
|
Term
Cholramphenicol binds ______. |
|
Definition
|
|
Term
Cholramphenicol inhibits ________. |
|
Definition
|
|
Term
Cholramphenicol also prevents _______ |
|
Definition
|
|
Term
Cholramphenicol disrupts:________ |
|
Definition
|
|
Term
Cholramphenicol can react with the ________ of Eukaryotic cells. |
|
Definition
|
|
Term
Cholramphenicol spectrum? |
|
Definition
|
|
Term
Cholramphenicol resistance is primarily from? |
|
Definition
****INACTIVATION – ACETYLATION |
|
|
Term
The resistance against Cholramphenicol by acetylation is gained via ______ from the ________? |
|
Definition
|
|
Term
If Cholramphenicol is acetylated it becomes ________. |
|
Definition
|
|
Term
The R-Factor Plasmid through acetylation grants resistance against: ______. |
|
Definition
CHLORAMPHENICOL, AMINOGLYCOSIDES (ALL), SULFONAMIDES |
|
|
Term
The R-Factor Plasmid through adenylation grants resistance against: ______. |
|
Definition
|
|
Term
The R-Factor Plasmid through phosphoryaltion grants resistance against: ______. |
|
Definition
|
|
Term
The R-Factor Plasmid through transporters grants resistance against: ______. |
|
Definition
|
|
Term
The R-Factor Plasmid through beta-lactamse grants resistance against: ______. |
|
Definition
|
|
Term
Cholramphenicol has good _______. |
|
Definition
|
|
Term
Because of its good CSF levels Cholramphenicol can be used to treat ________. |
|
Definition
|
|
Term
Cholramphenicol is metabolized by the ________ into _______. |
|
Definition
|
|
Term
With liver disease______ the dose of Cholramphenicol. |
|
Definition
|
|
Term
With kidney disease ______ the dose of Cholramphenicol. |
|
Definition
|
|
Term
Cholramphenicol is excreted by ______. |
|
Definition
|
|
Term
Bc Cholramphenicol is a broad spectrum it can cause a _______. |
|
Definition
|
|
Term
Cholramphenicols are metabolized by the liver via ________. |
|
Definition
|
|
Term
Cholramphenicol in its Glucuronide form is ______. |
|
Definition
|
|
Term
In neonates, Cholramphenicol toxicity can cause _______. |
|
Definition
|
|
Term
In neonates, Cholramphenicol toxicity can cause ***GRAY BABY SYNDROME, which is a failure to form ________ with inadequate ________ leading to ________ and __________. |
|
Definition
GLUCURONIC ACID (used to metabolize)
RENAL EXCRETION
HYPOTHERMIA / ACUTE VASCULAR COLLAPSE (40 % FATAL) |
|
|
Term
Cholramphenicol's main toxicity affects the _______ system by causing ________ or ________. |
|
Definition
Hematological
Transient bone marrow depression
Aplastic anemia |
|
|
Term
Cholramphenicol transient bone marrow depression is dose unrelated/related and reversible/irreversible. |
|
Definition
|
|
Term
Cholramphenicol aplastic anemia is dose unrelated/related and reversible/irreversible. |
|
Definition
|
|
Term
Cholramphenicol aplastic anemia has an onset of _______. |
|
Definition
Very delayed, months after dose |
|
|
Term
If the onset for Cholramphenicol aplastic anemia is ______ then the patient will survive. |
|
Definition
|
|
Term
If the onset for Cholramphenicol aplastic anemia is ______ then the patient will die. |
|
Definition
|
|
Term
Cholramphenicol toxicity can possibly be attributed to its effect on _______. |
|
Definition
|
|
Term
Cholramphenicol has physical incompatibilities with: __________. |
|
Definition
TETRACYCLINES POLYMYXIN B V ANCOMYCIN HYDROCORTISONE |
|
|
Term
If cephalosporins fail to treat _________, Cholramphenicol can then be used to treat. |
|
Definition
*SALMONELLA (TYPHOID FEVER |
|
|
Term
****If TETRACYCLINES fail to treat _________ or ________, Cholramphenicol can then be used to treat. |
|
Definition
*BRUCELLA (BRUCELLOSIS ****RICKETTSIAL DISEASES (RMSF) |
|
|
Term
If β-LACTAMS fail to treat _________, Cholramphenicol can then be used to treat. |
|
Definition
*NEISSERIA MENINGITIDIS (Chorl has good CSF levels) |
|
|
Term
Cholramphenicol has an antagonist interaction with? |
|
Definition
CHLORAMPHENICOL + ERYTHROMYCIN (COMPETE FOR 50S SUBUNIT) |
|
|
Term
Cholramphenicol has an synergistic interaction with? |
|
Definition
CHLORAMPHENICOL + PENICILLINS |
|
|
Term
Cholramphenicol has an overall drug interaction with other drugs because of its ________. |
|
Definition
|
|
Term
__________ and ________ decrease the half life of Cholramphenicol. |
|
Definition
|
|
Term
Aminoglycosides, Static or Cidal? |
|
Definition
|
|
Term
Aminoglycosides structure? |
|
Definition
|
|
Term
Aminoglycoside drugs can be distinguished by their ______ ending. |
|
Definition
|
|
Term
Aminoglycosides disrupt _______ by binding _______. |
|
Definition
Protein synthesis
30S (at 30S/50S interface) |
|
|
Term
Aminoglycosides mechanisms of action for disrupting protein synthesis: ___________. |
|
Definition
Block initiation of protein synthesis
Block further translation and causing premature termination of the 70S complex
Incorporation of the wrong AA |
|
|
Term
Aminoglycosides block the initiation of protein synthesis by inhibiting the binding of ______ to _______. |
|
Definition
*Met-amino-acyl tRNAs to ribosomes |
|
|
Term
For Aminoglycosides penetration of the cell wall is dependent upon _______. |
|
Definition
|
|
Term
Aminoglycosides can get through the ________ using passive transport without Oxygen. |
|
Definition
|
|
Term
Aminoglycosides can get through cell membrane into the cytoplasm using _________ with ________. |
|
Definition
|
|
Term
Aminoglycosides are not effective against? |
|
Definition
|
|
Term
Resistance against Aminoglycosides can be gained by a change in _____ structure. |
|
Definition
|
|
Term
The main mechanism for resistance for Aminoglycosides is __________. |
|
Definition
***Acetylation provided by the R factor |
|
|
Term
Acetylation of Aminoglycosides results in ______. |
|
Definition
|
|
Term
Aminoglycosides' absorption? |
|
Definition
Poor, cannot be administered orally |
|
|
Term
Aminoglycosides are administered via? |
|
Definition
|
|
Term
Aminoglycosides CSF concentration? |
|
Definition
|
|
Term
Aminoglycosides metabolism? |
|
Definition
|
|
Term
Aminoglycosides excretion? |
|
Definition
|
|
Term
Aminoglycosides, Static or Cidal? |
|
Definition
|
|
Term
Aminoglycosides structure? |
|
Definition
|
|
Term
Aminoglycoside drugs can be distinguished by their ______ ending. |
|
Definition
|
|
Term
Aminoglycosides disrupt _______ by binding _______. |
|
Definition
Protein synthesis
30S (at 30S/50S interface) |
|
|
Term
Aminoglycosides mechanisms of action for disrupting protein synthesis: ___________. |
|
Definition
Block initiation of protein synthesis
Block further translation and causing premature termination of the 70S complex
Incorporation of the wrong AA |
|
|
Term
Aminoglycosides block the initiation of protein synthesis by inhibiting the binding of ______ to _______. |
|
Definition
*Met-amino-acyl tRNAs to ribosomes |
|
|
Term
For Aminoglycosides penetration of the cell wall is dependent upon _______. |
|
Definition
|
|
Term
Aminoglycosides can get through the ________ using passive transport without Oxygen. |
|
Definition
|
|
Term
Aminoglycosides can get through cell membrane into the cytoplasm using _________ with ________. |
|
Definition
|
|
Term
Aminoglycosides are not effective against? |
|
Definition
|
|
Term
Resistance against Aminoglycosides can be gained by a change in _____ structure. |
|
Definition
|
|
Term
The main mechanism for resistance for Aminoglycosides is __________. |
|
Definition
***Acetylation provided by the R factor |
|
|
Term
Acetylation of Aminoglycosides results in ______. |
|
Definition
|
|
Term
Aminoglycosides' absorption? |
|
Definition
Poor, cannot be administered orally |
|
|
Term
Aminoglycosides are administered via? |
|
Definition
|
|
Term
Aminoglycosides CSF concentration? |
|
Definition
|
|
Term
Aminoglycosides metabolism? |
|
Definition
|
|
Term
Aminoglycosides excretion? |
|
Definition
|
|
Term
Aminoglycosides, Static or Cidal? |
|
Definition
|
|
Term
Aminoglycosides structure? |
|
Definition
|
|
Term
Aminoglycoside drugs can be distinguished by their ______ ending. |
|
Definition
|
|
Term
Aminoglycosides disrupt _______ by binding _______. |
|
Definition
Protein synthesis
30S (at 30S/50S interface) |
|
|
Term
Aminoglycosides mechanisms of action for disrupting protein synthesis: ___________. |
|
Definition
Block initiation of protein synthesis
Block further translation and causing premature termination of the 70S complex
Incorporation of the wrong AA |
|
|
Term
Aminoglycosides block the initiation of protein synthesis by inhibiting the binding of ______ to _______. |
|
Definition
*Met-amino-acyl tRNAs to ribosomes |
|
|
Term
For Aminoglycosides penetration of the cell wall is dependent upon _______. |
|
Definition
|
|
Term
Aminoglycosides can get through the ________ using passive transport without Oxygen. |
|
Definition
|
|
Term
Aminoglycosides can get through cell membrane into the cytoplasm using _________ with ________. |
|
Definition
|
|
Term
Aminoglycosides are not effective against? |
|
Definition
|
|
Term
Resistance against Aminoglycosides can be gained by a change in _____ structure. |
|
Definition
|
|
Term
The main mechanism for resistance for Aminoglycosides is __________. |
|
Definition
***Acetylation provided by the R factor |
|
|
Term
Acetylation of Aminoglycosides results in ______. |
|
Definition
|
|
Term
Aminoglycosides' absorption? |
|
Definition
Poor, cannot be administered orally |
|
|
Term
Aminoglycosides are administered via? |
|
Definition
|
|
Term
Aminoglycosides CSF concentration? |
|
Definition
|
|
Term
Aminoglycosides metabolism? |
|
Definition
|
|
Term
Aminoglycosides excretion? |
|
Definition
|
|
Term
Aminoglycosides' two main toxicities: ________. |
|
Definition
1) **8TH CRANIAL NERVE 2) **RENAL DAMAGE |
|
|
Term
Aminoglycosides' ototoxicity manifests as _______ or ______ damage. |
|
Definition
|
|
Term
Aminoglycosides' ototoxicity Auditory damage manifests as: ___________. |
|
Definition
TINNITUS HIGH – FREQUENCY HEARING LOSS |
|
|
Term
Aminoglycosides' ototoxicity Vestibular damage manifests as: ___________. |
|
Definition
VERTIGO ATAXIA LOSS OF BALANCE |
|
|
Term
Aminoglycosides' ototoxicity is resultant of damage to ______ and ______. |
|
Definition
|
|
Term
What frequency of hearing goes first with Aminoglycosides' ototoxicity? |
|
Definition
|
|
Term
Aminoglycosides exhibit synergistic ototoxicity with _______. |
|
Definition
ETHACRYNIC ACID / FUROSEMIDE (LOOP – INHIBITING DIURETICS) |
|
|
Term
Aminoglycosides cause renal toxicity because _______, which ends up damaging _________. |
|
Definition
Aminoglycosides get trapped in lyososomes
Brush border |
|
|
Term
Aminoglycosides exhibit synergistic renal toxicity with _______. |
|
Definition
Any drug that causes renal toxicity...
(don't know how impt: VANCOMYCIN AMPHOTERTICIN B CEPHALOSPORINS: EXAMPLE KEFLIN POLYMYXIN B) |
|
|
Term
Aminoglycosides are not to be administered to _______. |
|
Definition
|
|
Term
Just as with Tetracyclines, Aminoglycosides have the potential to cause ______ syndrome, which results in _______. |
|
Definition
Falconi Syndrome (from outdated drugs)
Decrease in electrolyte reabsorption |
|
|
Term
The Aminoglycoside, ___________, can be used to sterilize the bowel, because it ______. |
|
Definition
Neomycin
not absorbed orally |
|
|
Term
Neomycin is administered _______, because _________. |
|
Definition
|
|
Term
Gentamicin is a ________, it's structure is ________. |
|
Definition
AG
mixture of 3 sugars with 3 R groups |
|
|
Term
Gentamicin is ineffective in treating _________, because ________. |
|
Definition
Anaerobes (AGs)
need O2 for entry |
|
|
Term
|
Definition
|
|
Term
Gentamicin is the drug of choice for treating: ___________. |
|
Definition
*KLEBSIELLA PNEUMONIAE (HOSPITAL - ACQUIRED)
*PROTEUS MIRABILIS
**PSEUDOMONAS AERUGINOSA (resistance problem) |
|
|
Term
Aminoglycosides are used to treat _______ bacteria. |
|
Definition
|
|
Term
Aminoglycosides are used to treat when suspension of _____ in combination with _________. |
|
Definition
|
|
Term
β – LACTAM + Aminoglycosides has what three effects: ________. |
|
Definition
Extend coverage to gram + Increase cidal activity synerigism |
|
|
Term
Aminoglycosides + β – LACTAM are used to treat sepsis and _______ and ________ infections. |
|
Definition
ENTEROCOCAL ENDOCARDITIS
STAPHYLOCOCCAL ENDOCARDITIS |
|
|
Term
*GENTAMICIN + CEPHALOTHIN (KEFLIN® ) = ________ |
|
Definition
|
|
Term
*GENTAMICIN + POLYMYXIN B: = ________ |
|
Definition
|
|
Term
*GENTAMICIN + ETHACRYNIC ACID: = ________ |
|
Definition
|
|
Term
Spectinomycin can be used to treat _______ infections in substitute of __________. |
|
Definition
ACUTE GONOCOCCAL
**ALTERNATIVE: IF PENICILLIN ALLERGY / RESISTANCE |
|
|
Term
|
Definition
|
|
Term
|
Definition
– LOW RENAL TOXICITY (RARE) – NO OTOTOXICITY
(Low compared to true AGs) |
|
|
Term
Aminoglycoside, Cidal/Static? |
|
Definition
|
|
Term
CHLORAMPHENICOL, Cidal/Static? |
|
Definition
|
|
Term
TETRACYCLINES, Cidal/Static? |
|
Definition
|
|
Term
TETRACYCLINES, bind _______. |
|
Definition
|
|
Term
SPECTINOMYCIN, bind _______. |
|
Definition
|
|
Term
ERTHYROMYCIN, bind _______. |
|
Definition
|
|
Term
CLINDAMYCIN, bind _______. |
|
Definition
|
|
Term
AMINOGLYCOSIDES, bind _______. |
|
Definition
|
|
Term
Aminoglycosides have _______-dependent cidal activity. |
|
Definition
|
|
Term
Aminoglycoside's toxicity ______ is most critical. |
|
Definition
|
|
Term
Aminoglycosides (specifically Gentamicin) are dosed? |
|
Definition
|
|
Term
Dosage of Gentamicin (Aminoglycoside) varies with ___________. |
|
Definition
Renal Clearence (measured by Creatine clearance)
Decrease with lower clearance |
|
|
Term
Streptogramins A & B (________ & ______) |
|
Definition
Quinupristin & Dalfoprisitin
"prisitin " |
|
|
Term
Streptogramins A & B (Quinupristin & Dalfoprisitin) disrupt _______ by binding to _____. |
|
Definition
|
|
Term
Streptogramins A & B (Quinupristin & Dalfoprisitin) mechanism of action is ______. |
|
Definition
Inhbiting peptidyl transferase |
|
|
Term
Streptogramins A & B (Quinupristin & Dalfoprisitin) bind 50S at _______ and therefore _______. |
|
Definition
different sites on 50S
have synergestic effects |
|
|
Term
Quinupristin & Dalfoprisitin is used to treat __________. |
|
Definition
**VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM |
|
|
Term
Quinupristin & Dalfoprisitin is reserved for _____. |
|
Definition
|
|
Term
Quinupristin & Dalfoprisitin (Streptogramins) drug-drug interaction? |
|
Definition
Inhibit CYT P450
Increase activity of other drugs |
|
|
Term
Quinupristin & Dalfoprisitin (Streptogramins) toxicity? |
|
Definition
PHLEBITIS HYPERBILIRUBINEMIA |
|
|
Term
Oxazoladinones (Linezolid trade name) is used to treat ______ & ______. |
|
Definition
VANCOMYCIN - RESISTANT E. FAECIUM (VRE)
MRSA VRSA LRSA |
|
|
Term
Oxazoladinones (Linezolid trade name) disrupts _______ and binds to _______. |
|
Definition
Protein synthesis
50S at A site |
|
|
Term
Anti-Fungal Agents, Cell wall inhibitors: ______. |
|
Definition
|
|
Term
Anti-Fungal Agents, Cell membrane inhibitors: ______. |
|
Definition
Polyenes (Nystatin) Azoles |
|
|
Term
Anti-Fungal Agents, nuclear division inhibitors: ______. |
|
Definition
|
|
Term
Anti-Fungal Agents, nucleic acid (DNA/RNA) inhibitors: ______. |
|
Definition
|
|
Term
Nystatin is a _________, with a _______ structure, antifungal agent. |
|
Definition
|
|
Term
Does Nystatin posses antibacterial capabilities? |
|
Definition
|
|
Term
Nystatin main use is against ______. |
|
Definition
|
|
Term
Nystatin mechanism of action: _________. |
|
Definition
Increase the permeability of the membrane |
|
|
Term
Nystatin Increases the permeability of the membrane, which causes the ________. |
|
Definition
|
|
Term
If __________, then the fungus is sensitive to Nystatin |
|
Definition
There are no sterols in media |
|
|
Term
Nystatin has selective binding toxicity with ________, which affects ______ and ______. |
|
Definition
Lysosomal Membranes
RBC hemolysis
Kidney Damage |
|
|
Term
Nystatin is administered _______. |
|
Definition
|
|
Term
Nystatin displays selective binding toxiciity when _______. |
|
Definition
Administered systemically |
|
|
Term
Nystatin is used as an ointment to treat _______ and topically to treat _______ and orally to treat ______. |
|
Definition
Candida
Moniliasis skin
Moniliasis GI |
|
|
Term
Overall Nystatin is used to treat ______ infections. |
|
Definition
|
|
Term
Amphotericin B is a _________, with a _______ structure, antifungal agent. |
|
Definition
Macrolide with a *Polyene |
|
|
Term
Amphotericin B binds to ________ causing ________ by ________. |
|
Definition
Fungal Membranes
Ions to leak out
Causing pores to form in the membrane |
|
|
Term
Amphotericin B has selectivity of action against __________. |
|
Definition
|
|
Term
Amphotericin B is administered ______. |
|
Definition
|
|
Term
Amphotericin B toxicity with IV admin? |
|
Definition
Thrombophlebitis (WIKI inflammation of a vein caused by a blood clot.) |
|
|
Term
Plasma Concentration target for Amphotericin B? |
|
Definition
2x needed to kill in vitro (vs 4x as with other antibiotics) |
|
|
Term
Amphotericin B can be administered to treat _____________, but runs the side effect of developing __________. |
|
Definition
intrathecally
FUNGAL MENINGITIS
CHEMICAL MENINGITIS |
|
|
Term
|
Definition
introduced into or occurring in the space under the arachnoid membrane of the brain or spinal cord |
|
|
Term
Amphotericin B's most common, but not most serious, toxicity is _________, resulting from a ________. |
|
Definition
Anemia
Decrease in the production of erythroid proteins |
|
|
Term
Amphotericin B anemia toxicity is treated with _______. |
|
Definition
|
|
Term
Amphotericin B's primary toxicity of concern is ________. |
|
Definition
|
|
Term
Amphotericin B's renal toxicity consists of: ____________. |
|
Definition
Increase BUN Increase Serum Creatine Decrease Urea Clearance Decrease ability to concentrate Deposition of Ca2+ in kindeys Renal Tubular Alkalosis |
|
|
Term
Amphotericin B is dosed _________. |
|
Definition
|
|
Term
Amphotericin B permanent kidney damage occurs when ______. |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Ketoconazole is administered? |
|
Definition
|
|
Term
Ketoconazole is used to treat _________ infections. |
|
Definition
|
|
Term
***Ketoconazole's main issue is that it __________, which interferes with ________ and ________, leading to _________. |
|
Definition
Decreases CYT P450 activity
Interferes with steroid biosynthesis Metabolism of other drugs (gyneomastia) |
|
|
Term
Ketoconazole mechanism of action? |
|
Definition
Inhibits ergosterol synthesis |
|
|
Term
ergosterol is essential for _______. |
|
Definition
|
|
Term
Ketoconazole has partially replaced ________. |
|
Definition
|
|
Term
Itraconazole mechanism of action? |
|
Definition
Inhibits ergosterol synthesis |
|
|
Term
Itraconazole is related to ______. |
|
Definition
|
|
Term
Itraconazole advantage over Ketoconazole? |
|
Definition
|
|
Term
Voriconazole main advantage, ______. |
|
Definition
|
|
Term
Voriconazole is used to treat ______. |
|
Definition
|
|
Term
Voriconazole mechanism of action? |
|
Definition
Inhibits ergosterol synthesis |
|
|
Term
Miconazole mechanism of action? |
|
Definition
Inhibits ergosterol synthesis |
|
|
Term
Miconazole is administered _______. |
|
Definition
Topically, too toxic to be systemically |
|
|
Term
Miconazole is used topically to treat _______ and ___________. |
|
Definition
Candida Albicans (skin and vagina)
Tinea (ringworm) |
|
|
Term
Miconazole is used to treat Tinea (ringworm) which includes: __________. |
|
Definition
PEDIS (FEET) CRURIS (THIGHS, PERINEUM) VESICOLOR (TRUNK) |
|
|
Term
Which azole has good CSF penetration? |
|
Definition
|
|
Term
Fluconazole mechanism of action? |
|
Definition
Inhibits ergosterol synthesis |
|
|
Term
|
Definition
Teratogenic (SKELETAL / CARDIAC DEFORMITIES)
**Rash (AIDS patient) Stevens-Johnson Syndrome (AIDS) Liver (AIDS) Thrombocytopenia (AIDS) |
|
|
Term
Fluconazole drug drug interaction: ________. |
|
Definition
* Increase Phenytoin Increase Sulfonylureas Increase Warfarin Increase Cyclosporin |
|
|
Term
Main issue with Fluconazole usage? |
|
Definition
*Developing resistance [ ESPECIALLY PROPHYLACTIC USE – TRANSPLANT / AIDS ] |
|
|
Term
Fluconazole is used to treat: ________. |
|
Definition
*Oral/Esophageal Candidiasis (AIDS have issues, but still used)
*Cryptococcal Meningitis relapse after Amp B administration (Good CSF penetration, but AIDS patient trouble)
Coccidioidal Meningitis (Good CSF Pen) |
|
|
Term
_________ is the broadest spectrum of all the Azoles? |
|
Definition
|
|
Term
Griseofulvin mechanism of action? |
|
Definition
|
|
Term
Griseofulvin is used to treat: _______. |
|
Definition
Candida Albicans
Ringworm: Microsporum Trichophyton Epidermophyton |
|
|
Term
Griseofulvin route of administration? |
|
Definition
|
|
Term
Griseofulvin absorption can be increased by? |
|
Definition
|
|
Term
Griseofulvin treatment duration? |
|
Definition
4-6 weeks skin
Months for nails |
|
|
Term
Griseofulvin treats ______ infections of the skin, hair, and nails. |
|
Definition
|
|
Term
Griseofulvin primary side effect is ________ and has a drug drug interaction with ______, which causes _________. |
|
Definition
Headache
Warfarin, increase its metabolism |
|
|
Term
Griseofulvin's therapeutic effect is in treating ________ foot and fungal infections of the _____ & ______. |
|
Definition
|
|
Term
Griseofulvin is a Cidal/Static agent? |
|
Definition
Static (why takes so long)) |
|
|
Term
Flucytosine undergoes _____ in the fungal cell. |
|
Definition
|
|
Term
Flucytosine undergoes Lethal synthesis in the fungal cell, converting it from the ______ form, Flucytosine, to the ________ form, ___________. |
|
Definition
prodrug
active/antimetabolite
5-Flurouracil |
|
|
Term
What does 5-Flurouracil do? |
|
Definition
Inhibits Thymidylate synthesis disrupting nucleic acid synthesis |
|
|
Term
5-Flurouracil (Flucytosine) is administered? |
|
Definition
Not as a single drug, but in combination with other drugs bc of resistance |
|
|
Term
5-Flurouracil (Flucytosine) is combined with ______ or ______ because of emerging resistance problems. |
|
Definition
|
|
Term
5-Flurouracil (Flucytosine) is used mainly to treat __________. |
|
Definition
|
|
Term
5-Flurouracil (Flucytosine) admin route? |
|
Definition
|
|
Term
5-Flurouracil (Flucytosine) is more toxic in __________. |
|
Definition
|
|
Term
5-Flurouracil (Flucytosine)'s main toxicity is _______. |
|
Definition
**Serious bone marrow depression |
|
|
Term
Antifungals can be potentated by being combined with ________. |
|
Definition
|
|
Term
Terbinafine ( a Allylamine) mechanism of aciton? |
|
Definition
Inhibits Squalene epoxidase (part of ergosterol synthesis |
|
|
Term
Terbinafine ( a Allylamine) main side effect? |
|
Definition
|
|
Term
Terbinafine ( a Allylamine) is used to treat _______ & _______? |
|
Definition
ATHELETE’S FOOT, RINGWORM |
|
|
Term
Terbinafine ( a Allylamine) and P450? |
|
Definition
|
|
Term
|
Definition
caspoFUNGIN micaFUNGIN anidulaFUNGIN |
|
|
Term
Echinocandins mechanism of action? |
|
Definition
1,3- β-GLUCAN SYNTHASE INHIBITORS, which blocks cell wall synthesis |
|
|
Term
Caspofungin is used to treat _________. |
|
Definition
Invasive Aspergillos
Mucocutaneous Candidas
Bld Stream Candidas |
|
|
Term
Micafungin is used to treat __________. |
|
Definition
Esophageal Candididasis (HIV + Patients) |
|
|
Term
Anidulafungin is used to treat __________. |
|
Definition
|
|
Term
|
Definition
|
|
Term
Phenobarbital lowers the serum levels of ________, having an absorption effect. |
|
Definition
|
|
Term
**Griseofulvin induces ______ enzymes and leads to a decrease in ___________. |
|
Definition
Microsomal enzymes
Warfarin |
|
|
Term
**Griseofulvin induces _______ which can cause Porphyria. |
|
Definition
δ - AMINOLEVULINIC ACID SYNTHETASE |
|
|
Term
Major Agents of Anti-TB: ________. |
|
Definition
INH Rifampin Ethambutol Pyrazinamide Streptomycin |
|
|
Term
For INH RESISTANCE <4%, TB Drug Regiment: __________. |
|
Definition
INH Rifampin Ethambutol Pyrazinamide |
|
|
Term
For INH RESISTANCE >4%, TB Drug Regiment: __________. |
|
Definition
Rifampin Ethambutol Pyrazinamide Fluroquinolone |
|
|
Term
Have to undergo DRUG REGIMEN (IRPE/S) if you meet any of these criteria: ___________. |
|
Definition
*PREVIOUS EXPOSURE TO DRUG - RESISTANT TB *ASIANS & HISPANICS IF RECENT IMMIGRANTS *MILIARY TB (NODULES & disseminated) *TB MENINGITIS *EXTENSIVE PULMONARY DISEASE *HIV |
|
|
Term
After treatment for TB, should see results within ______. |
|
Definition
|
|
Term
______ anti TB drug can be used prophylactically for those ________. |
|
Definition
Exposed to TB, but no infection + skin test, but no disease HIV |
|
|
Term
|
Definition
|
|
Term
|
Definition
be cleaved to active form |
|
|
Term
Isoniazid, prodrug, is cleaved by _______ into _______, the active form of the drug. |
|
Definition
Catalase/Peroxidase
Isonicotinic Acid |
|
|
Term
Isonicotinic Acid affects the TB cell by: ________. |
|
Definition
causing H2O2 to increase and target small molecules (Minor)
**Decreasing Mycolic Acid synthesis leading to cell wall synthesis |
|
|
Term
|
Definition
|
|
Term
Mycobacterium have _____ in their cell walls. |
|
Definition
|
|
Term
|
Definition
|
|
Term
Isoniazid has a ______ problem. |
|
Definition
|
|
Term
____ % of strains of TB are Isoniazid resistant in US. |
|
Definition
|
|
Term
Isoniazid resistance is conferred by a mutation in _____ that results in _______. |
|
Definition
**Catalase, reduced activity |
|
|
Term
Isoniazid resistance is conferred by an alteration in biosynthesis of _____ that results in _______. |
|
Definition
Mycolic acid
less inhibition |
|
|
Term
**Isoniazid is metabolized by _________, which results in ________. |
|
Definition
|
|
Term
Isoniazid can be _______ into its active form ISONICOTINIC ACID or it can be ________ into its inactive form. |
|
Definition
|
|
Term
Metabolism of Isoniazid varies between _______. |
|
Definition
Fast and slow acetylators |
|
|
Term
Fast and slow acetylators is determined by _______. |
|
Definition
|
|
Term
Fast acetylators: __________. |
|
Definition
|
|
Term
Acetylator activity is determined by levels of ________ enzyme. |
|
Definition
|
|
Term
Fast Acetylator genotype is inherited __________. |
|
Definition
|
|
Term
Acetylation activity of Isoniazid affects ________ toxicity. |
|
Definition
|
|
Term
Isoniazid can cause Pyridoxine Deficiency (especially ______ aceylators), because _______. |
|
Definition
|
|
Term
**Isoniazid's two main toxicities: ___________. |
|
Definition
Peripheral Neuropathy
Hepatic |
|
|
Term
**Isoniazid's Peripheral Neuropathy toxicity is due to ________ and is treated by __________. |
|
Definition
Isoniazid and B6 structure similarity
Supplemental B6 (slow and fast acetyl) |
|
|
Term
**The hepatotoxicity associated with Isoniazid use risk is increased with ______. |
|
Definition
|
|
Term
**The Isoniazid hepatotoxicity causes __________. |
|
Definition
Hepatitis (liver necrosis) |
|
|
Term
*When administering Isoniazid, especially to _______, ________ needs to be monitored, especially if being taken with ______.. |
|
Definition
children
Liver function tests
Rifampin |
|
|
Term
INH is the only drug used for _______. |
|
Definition
|
|
Term
Ethambutol is a ________. |
|
Definition
|
|
Term
Ethambutol mechanism of action: _______. |
|
Definition
Inhibits Arabinosyl transferase (Cell wall inhibitor) |
|
|
Term
|
Definition
|
|
Term
Ethambutol's main toxicity? |
|
Definition
|
|
Term
Ethambutol's main toxicity, Retrobulbar Neuritis, manifests as ________. |
|
Definition
Loss of visual acuity Red Green color blindness |
|
|
Term
Before giving Ethambutol you must? |
|
Definition
Test visual acuity and color blindness |
|
|
Term
Rifampin is a ______ anti TB agent. |
|
Definition
|
|
Term
*Rifampin is used to treat: ______. |
|
Definition
Systemic TB TB Meninigitis MENINGOCOCCAL carrier state (cause of meningitis) |
|
|
Term
Rifampin binds to _______ and blocks ________. |
|
Definition
DNA dependent RNA Pol
Transcription of RNA |
|
|
Term
**Rifampin has no effect on __________. |
|
Definition
Mammalian DNA dependent RNA Pol |
|
|
Term
Rifampin resistance comes from a mutation in _______. |
|
Definition
|
|
Term
Rifampin has very good distribution especially _______. |
|
Definition
|
|
Term
Rifampin toxicity overall is? |
|
Definition
|
|
Term
Rifampin Main toxicities: __________. |
|
Definition
***Hepatitis (rare, 1/30,000 have to worry when combined with INH)
**Orange stain teats/sweat (contacts)
**Flu like symptoms |
|
|
Term
Rifampin is used to treat: __________. |
|
Definition
**Active TB
**Meningococcal
**TB meningitis
M. leprae |
|
|
Term
|
Definition
Mycobacterium (leprae/TB)
Some gram + |
|
|
Term
Rifampin's main drug drug interaction is __________, because it is a _____________. |
|
Definition
Decrease the half life of other drugs *Oral contraceptives (double whammy bc also kills the bacteria used to regen)
Potent inducer of liver microsomal enzymes |
|
|
Term
Pyrazinamide, primary or secondary? |
|
Definition
|
|
Term
Pyrazinamide mechanism of action? |
|
Definition
Lowers pH leading to no growth for mycobacteria
Disrupt mycolic acid |
|
|
Term
|
Definition
|
|
Term
Pyrazinamide main toxicity? |
|
Definition
|
|
Term
Because of Pyrazinamide's liver toxicity you must _______. |
|
Definition
|
|
Term
Pyrazinamide toxicity is ______. |
|
Definition
Tolerable for short durations |
|
|
Term
Streptomycin, primary or secondary? |
|
Definition
|
|
Term
Streptomycin main toxicities? |
|
Definition
|
|
Term
Streptomycin class of drugs? |
|
Definition
|
|
Term
Cycloserine primary or secondary? |
|
Definition
|
|
Term
Cycloserine MOA: _______. |
|
Definition
|
|
Term
Cycloserine main toxicities: ____________. |
|
Definition
*Periph Neuropathy
*CNS dysfunction (depression etc.)
*Grand MAL/ Petit MAL convulsions (seizures), especially when combined with ALCOHOL* |
|
|
Term
Cycloserine is not recommend for: _______. |
|
Definition
|
|
Term
Cycloserine is administered with _______ in order to __________. |
|
Definition
|
|
Term
Ethionamide is a ______ drug. |
|
Definition
|
|
Term
Ethionamide main toxicities: ________. |
|
Definition
*GI *Depression *Neurological (vision) |
|
|
Term
Capreomycin is a ______ drug and _____ chemical class. |
|
Definition
Secondary AntiTB
Cyclic Peptide |
|
|
Term
|
Definition
|
|
Term
Kanamycin is a ______ drug and _____ chemical class. |
|
Definition
|
|
Term
|
Definition
|
|
Term
Which secondary AntiTB agent is rarely used? |
|
Definition
Aminosalicylic Acid (PAS) |
|
|
Term
Aminosalicylic Acid (PAS) is rarely used as secondary AntiTB agent because of its ________. |
|
Definition
***GI problems
***Compliance (won't take bc of GI problems)
*Hypersensitivity |
|
|
Term
Aminosalicylic Acid (PAS) MOA: ________. |
|
Definition
Inhibits coupling enzyme, disrupting Folic acid synthesis |
|
|
Term
______ + _______ increases hepatoxicity for AntiTB drugs. |
|
Definition
|
|
Term
______ + _______ causes absorption problems for AntiTB drugs |
|
Definition
Rifampin + Aminosalicylic Acid (PAS) |
|
|
Term
______ antiTB agent interferes with oral contraceptives use. |
|
Definition
|
|
Term
_______ antiTB agent induces _________ leading to a ________ for other drugs, especially _________. |
|
Definition
*Rifampin
Liver microsomal enzymes
decrease in T1/2
Oral contraceptives |
|
|
Term
**Dapsone is a _______ drug. |
|
Definition
Anti-Leprosay (Hansen's Disease) |
|
|
Term
Dapsone is related to _____ drugs. |
|
Definition
|
|
Term
|
Definition
*Inhibits Folic Acid Synthesis
*Competes with PABA |
|
|
Term
Dapsone Toxicities: __________. |
|
Definition
GI
Blood Dyscrasis (Hemolytic anemia & Methemoglobinenmia) |
|
|
Term
Dapsone causes Hemolytic anemia in ________. |
|
Definition
|
|
Term
Dapsone causes Methemoglobinenmia by __________. |
|
Definition
|
|
Term
Anti-Leprosay is accomplished through ______ drug therapy. |
|
Definition
|
|
Term
_______ Anti-Leprosay drug is not used anymore because of it causing the birth defect _______. |
|
Definition
|
|
Term
Anti-Leprosay treatment minimum time frame ______. |
|
Definition
|
|
Term
MYCOBACTERIUM AVIUM COMPLEX is treated using ______ drug therapy. |
|
Definition
|
|
Term
Most common species of Plasmodium? |
|
Definition
|
|
Term
Most lethal species of Plasmodium? |
|
Definition
|
|
Term
P. Falciparum fever pattern? |
|
Definition
Quotidian (Every day) or *Irregular |
|
|
Term
|
Definition
Tertain
(EVERY OTHER, 3RD DAY) |
|
|
Term
P. Malariae ever pattern? |
|
Definition
Quartan (EVERY 3 DAYS) 4TH DAY |
|
|
Term
|
Definition
Tertain
(EVERY OTHER, 3RD DAY) |
|
|
Term
P. Falciparum causes ______ Tertain malaria. |
|
Definition
|
|
Term
Liver dormant capable Plasmodium: ________. |
|
Definition
|
|
Term
**Strictly erythrocyte form plasmoidum: ________. |
|
Definition
|
|
Term
P. Falciparum & P. Malariae, how many cycles of liver invasion? |
|
Definition
|
|
Term
P. Vivax & P. Ovale can relapse between blood and liver, what is the term for this? |
|
Definition
|
|
Term
Chloroquine is a ________ class of drug that targets ________ form. |
|
Definition
4-Aminoquinolones
BLOOD SCHIZONTICIDE
Blood |
|
|
Term
4-Aminoquinolone class MOA: ____________. |
|
Definition
Inhibits DNA synthesis by intercalating
Build up free heme |
|
|
Term
Chloroquine toxicity: _______. |
|
Definition
*Ocular toxic Excreted in tears and reabsorbed by cornea
**Cardiac Hypotension/Arrest
**RBC Hemolytic Anemia |
|
|
Term
Chloroquine has a low _______. |
|
Definition
|
|
Term
Chloroquine is contradicted for: ___________. |
|
Definition
**Retinal/Visual abnormalities
**Alcoholism
**Neurological Disorders (epilipsy)
***Hematologic Disorders (G6PDH Defic) |
|
|
Term
Chloroquine targets _____ forms. |
|
Definition
|
|
Term
Chloroquine is uses: __________. |
|
Definition
*Suppressive Prophylatic
**8Terminates the acute attacks and cures Falciparum/Malariae
****Terminates acute attack, no cure Vivax/Ovale |
|
|
Term
Chloroquine is not effective against _______. |
|
Definition
|
|
Term
Chloroquine *Suppressive Prophylatic treatment schedule? |
|
Definition
500mg/weekly 3 weeks before during and 3 weeks after |
|
|
Term
Amodiaquine is a _______ class of drugs. |
|
Definition
|
|
Term
Amodiaquine is similar to _______. |
|
Definition
|
|
Term
Unlike Amodiaquine is not used _______. |
|
Definition
for Suppressive Prophylatic |
|
|
Term
Why is Amodiaquine not used for Suppressive Prophylaxis? |
|
Definition
Toxicity increases with long term use |
|
|
Term
Chloroquine MOA: __________ |
|
Definition
(4-Aminoquinolone) Inhibits DNA synthesis by intercalating
Build up free heme |
|
|
Term
Amodiaquine MOA: __________ |
|
Definition
(4-Aminoquinolone) Inhibits DNA synthesis by intercalating
Build up free heme |
|
|
Term
Artemisinin is used to treat _______. |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Heme iron damage/ Alkylation |
|
|
Term
Artemisinin is used ________. |
|
Definition
in combination, because of resistance concern |
|
|
Term
Artemisinin is used in combination with |
|
Definition
CHLOROQUINE / AMODIAQUINE SOME/ MEFLOQUINE |
|
|
Term
Mefloquine is a _______ class of drug. |
|
Definition
|
|
Term
Mefloquine targets the _______ forms. |
|
Definition
|
|
Term
|
Definition
**Prophylaxis + Treatment of Chloroquine-resistant and multi-resistant Falciiparum
(Chloroquine is usually used for propholyatic) |
|
|
Term
Mefloquine is propholyatic against? |
|
Definition
|
|
Term
Mefloquine is contradicted in: _______. |
|
Definition
People with epilipsy Mood disorders (causes risk of suicide/weird dreams) Cardiac Conditions (exacerbates them) |
|
|
Term
Quinine targets _____ forms. |
|
Definition
|
|
Term
|
Definition
|
|
Term
Quinine is a _______ Schizonticide for _______ parasites. |
|
Definition
|
|
Term
Quinine kills the gametophytes of __________. |
|
Definition
|
|
Term
Quinine is/isn't effective against liver forms? |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
**Cinchonism (overdose of Quinine)
**Blackwater Fever |
|
|
Term
**Cinchonism (overdose of Quinine) manifests with: ___________. |
|
Definition
Ototoxic GI Toxicity Visual Toxicity (retinal toxicity, blindness) |
|
|
Term
In addition to Cinchonism, Quinine can be toxic by causing _______, especially dangerous for __________. |
|
Definition
*Hypoglycemia
Pregnant women |
|
|
Term
Quinine **Blackwater Fever has a ______% fatality rate. |
|
Definition
|
|
Term
Quinine **Blackwater Fever manifests itself: ____________. |
|
Definition
Hemolysis Renal Failure G6PDH Deficiency |
|
|
Term
Quinine is contradicted for: ________. |
|
Definition
G6PDH Deficiency History of: Tinnitus, optic neuritis, myasthenia gravis |
|
|
Term
Quinine main use it to treat ______. |
|
Definition
|
|
Term
Quinine can also be used to treat Falciparum that is _______ resistant. |
|
Definition
|
|
Term
|
Definition
Quinidine is more potent/toxic |
|
|
Term
Primaquine is ______ class of drug. |
|
Definition
|
|
Term
Primaquine is used to treat ______ form. |
|
Definition
|
|
Term
Primaquine is a _______ Schizonticide. |
|
Definition
|
|
Term
****Primaquine can be combined with _______ to be used as a radical cure for _______. |
|
Definition
Chloroquine (get RBC form)
Vivax/ Ovale |
|
|
Term
Primaquine is the primary _______ treatment. |
|
Definition
|
|
Term
Primaquine Toxicity: ________. |
|
Definition
** Hemolytic Anemia (G6PDH) Methemoglobinemia (G6PDH) |
|
|
Term
______, _______, & __________ anti malarial agents that affect individuals with G6PDH deficiency. |
|
Definition
Primaquine Quinine Chloraquine |
|
|
Term
Anti-folate anti-malaria drugs: ________. |
|
Definition
|
|
Term
Biguanide must __________. |
|
Definition
be metabolized in the liver from its pro form to active drug, dihydrotriazine |
|
|
Term
Anti bacterial small molecule antifolate, __________. |
|
Definition
|
|
Term
Primethamine MOA: ________. |
|
Definition
Inhibits Dihydrofolate reductase |
|
|
Term
Malaria can also be treated by ______ drugs which are also anti-bacterial. |
|
Definition
|
|
Term
Sulfanomides MOA: _________. |
|
Definition
Compete with PABA and inhibit the Coupling Enzyme (Dihydropteroate Synthase) |
|
|
Term
Sulfanomides are _____ acting Anti-Malaria drugs. |
|
Definition
|
|
Term
Atovaquone-Proguanil is used for _________. |
|
Definition
PROPHYLAXIS / TREATMENT of Chloroquine resistant Falciparum |
|
|
Term
Atovaquone-Proguanil MOA: _________. |
|
Definition
Inhibits MT Electron Transport
Inhibits Folate Reductase |
|
|
Term
Babesiosis is a rare severe ___________. |
|
Definition
|
|
Term
Babesiosis affects __________. |
|
Definition
Elderly/Immunocompromised |
|
|
Term
Babesiosis manifests: __________. |
|
Definition
Fever and *Hemolytic Anemia |
|
|
Term
Babesiosis is treated with: __________. |
|
Definition
|
|
Term
Babesiosis is treated with Quinine and Clindamycin, MOA? |
|
Definition
Quinine: Inhibit DNA synthesis and Heme buildup
Clindamycin: inhibits translocation |
|
|
Term
Amebicide that is a tissue and luminal (not reliable)? |
|
Definition
|
|
Term
Metronidazole is a _____ drug and is _________. |
|
Definition
Prodrug
activated in anaerobic conditions |
|
|
Term
Metronidazole is used to treat: _______. |
|
Definition
Ameba, Giardia, Trichomonas
Anaerobic Bacteria |
|
|
Term
Indirect acting Luminal Amebicides: ___________. |
|
Definition
(affect the bacteria supporting it) TETRACYCLINES ERYTHROMYCIN PAROMOMYCIN (also direct) |
|
|
Term
Direct acting Luminal Amebicides: ___________. |
|
Definition
DIIODOHYDROXYQUIN PAROMOMYCIN (also indirect) DILOXANIDE FUROATE |
|
|
Term
Tissue Amebicides: ___________. |
|
Definition
EMETINE / DEHYDROEMETIN Chloroquine |
|
|
Term
EMETINE / DEHYDROEMETIN toxicity? |
|
Definition
|
|
Term
Melarsoprol is used to treat: _______. |
|
Definition
African Sleeping Sickeness |
|
|
Term
|
Definition
|
|
Term
Why is Melarsoprol so neurotoxic? |
|
Definition
|
|
Term
Pentamidine is used to treat: ____________. |
|
Definition
Pneumocycstis Jiroveci (AIDS) Trypansomes (sleeping sickness) |
|
|
Term
|
Definition
Severe hyptoension if IV too quickly |
|
|
Term
SODIUM Stibogluconate used to treat? |
|
Definition
LEISHMANIASIS (TRANSMITTED BY SANDFLY) |
|
|
Term
SODIUM Stibogluconate toxicity? |
|
Definition
|
|
Term
Nifurtimox/Benznidazole used to treat? |
|
Definition
CHAGA’S DISEASE (TRYPANOSOMIASIS) |
|
|
Term
|
Definition
**Metronidazole, NITAZOXANIDE
TINIDAZOLE less toxicity |
|
|
Term
Vaginal TRICHOMONIASIS Treatment? |
|
Definition
|
|
Term
Thiabendazole is used to treat? |
|
Definition
*Trichinella (Raw pork/beef) NEMATODES |
|
|
Term
|
Definition
Inhibiting Fumarate Reductase |
|
|
Term
Albendazole is used to treat? |
|
Definition
|
|
Term
|
Definition
Inhibiting Fumarate Reductase |
|
|
Term
|
Definition
Broad spectrum of NEMATODES |
|
|
Term
|
Definition
Impairs GLC uptake by nematode leading to its paralysis |
|
|
Term
Ascaris + Hookworms treated with? |
|
Definition
Mebendazole or Albendazole |
|
|
Term
Thiabendazole is being replaced by? |
|
Definition
Mebendazole & Albendazole |
|
|
Term
Praziquantal is used to treat? |
|
Definition
****Schistosomiasis and Liver Flukes
Broad spectrum |
|
|
Term
Praziquantal MOA: __________. |
|
Definition
Increases permability, causing influx of Ca2+, Paralysis of Fluke |
|
|
Term
Praziquantal is not to be used by __________. |
|
Definition
|
|
Term
Praziquantal cross problem: __________. |
|
Definition
Ocular Cysticercosis (pork tapeworm)
kill tapeworm in eye -> ocular lesions |
|
|